TXK
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
Y Sites Probabilities
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0FGR8 | Y824 | Sugiyama | ESYT2 FAM62B KIAA1228 | IVVVHACRNLIAFSEDGsDPyVRMYLLPDKRRSGRRKTHVS |
| A1X283 | Y855 | Sugiyama | SH3PXD2B FAD49 KIAA1295 TKS4 | NREKAAAASVPNADGLKDSLyVAVADFEGDKDTSSFQEGTV |
| A5A3E0 | Y1062 | Sugiyama | POTEF A26C1B | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCL_______ |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| A5YKK6 | Y1572 | Sugiyama | CNOT1 CDC39 KIAA1007 NOT1 AD-005 | RMPEQIRLKVGGVDPKQLAVyEEFARNVPGFLPTNDLSQPT |
| O00116 | Y645 | Sugiyama | AGPS AAG5 | QWLKESIsDVGFGMLKSVKEyVDPNNIFGNRNLL_______ |
| O00233 | Y70 | Sugiyama | PSMD9 | IGMNEPLVDCEGyPRSDVDLyQVRTARHNIICLQNDHKAVM |
| O00401 | Y256 | Sugiyama | WASL | FDMCGIsEAQLKDRETSKVIyDFIEKTGGVEAVKNELRRQA |
| O00429 | Y101 | Sugiyama | DNM1L DLP1 DRP1 | EENGVEAEEWGKFLHTKNKLyTDFDEIRQEIENETERISGN |
| O00469 | Y586 | Sugiyama | PLOD2 | FWFPIFSEKACDELVEEMEHyGKWSGGKHHDsRIsGGyENV |
| O14579 | Y304 | Sugiyama | COPE | HPFIKEYQAKENDFDRLVLQyAPsA________________ |
| O14818 | Y176 | Sugiyama | PSMA7 HSPC | WKANAIGRGAKSVREFLEKNyTDEAIETDDLTIKLVIKALL |
| O14910 | Y133 | Sugiyama | LIN7A MALS1 VELI1 | KTDEGLGFNVMGGKEQNsPIyIsRIIPGGVAERHGGLKRGD |
| O14950 | Y143 | Sugiyama | MYL12B MRLC2 MYLC2B | LRELLttMGDRFtDEEVDELyREAPIDKKGNFNyIEFtRIL |
| O14950 | Y156 | Sugiyama | MYL12B MRLC2 MYLC2B | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| O15013 | Y1307 | Sugiyama | ARHGEF10 KIAA0294 | sLsLsHGsssLEHRSEDsTIyDLLKDPVSLRSKARRAKKAK |
| O15067 | Y538 | Sugiyama | PFAS KIAA0361 | GAGGNGNVLKELsDPAGAIIytsRFQLGDPTLNALEIWGAE |
| O15230 | Y81 | Sugiyama | LAMA5 KIAA0533 KIAA1907 | SATCGEEAPARGSPRPTEDLyCKLVGGPVAGGDPNQTIRGQ |
| O15357 | Y886 | Sugiyama | INPPL1 SHIP2 | IRGSMKVRVPTERLGTRERLyEWISIDKDEAGAKSKAPSVS |
| O15371 | T49 | Sugiyama | EIF3D EIF3S7 | PyQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGGSQY |
| O15371 | Y30 | Sugiyama | EIF3D EIF3S7 | QDNPSGWGPCAVPEQFRDMPyQPFsKGDRLGKVADWtGAty |
| O15371 | Y50 | Sugiyama | EIF3D EIF3S7 | yQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGGSQYA |
| O15397 | Y995 | Sugiyama | IPO8 RANBP8 | WYQLLMAPLSEDQRTALQEVyTLAEHRRTVAEAKKKIEQQG |
| O15460 | Y342 | Sugiyama | P4HA2 UNQ290/PRO330 | LLIAPFKEEDEWDSPHIVRYyDVMsDEEIERIKEIAKPKLA |
| O43143 | Y128 | Sugiyama | DHX15 DBP1 DDX15 | HTSLPQCINPFTNLPHTPRyyDILKKRLQLPVWEYKDRFTD |
| O43172 | Y32 | Sugiyama | PRPF4 PRP4 | TKTKAPDDLVAPVVKKPHIyyGsLEEKERERLAKGESGILG |
| O43252 | Y238 | Sugiyama | PAPSS1 ATPSK1 PAPSS | ELLQERDIVPVDAsYEVKELyVPENKLHLAKTDAETLPALK |
| O43390 | Y136 | Sugiyama | HNRNPR HNRPR | QESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O43390 | Y296 | Sugiyama | HNRNPR HNRPR | VILYHQPDDKKKNRGFCFLEyEDHKSAAQARRRLMSGKVKV |
| O43390 | Y376 | Sugiyama | HNRNPR HNRPR | ILEKSFSEFGKLERVKKLKDyAFVHFEDRGAAVKAMDEMNG |
| O43390 | Y435 | Sugiyama | HNRNPR HNRPR | KRKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGGR |
| O43684 | Y141 | Sugiyama | BUB3 | KLWDPRtPCNAGTFsQPEKVytLSVSGDRLIVGTAGRRVLV |
| O43707 | Y212 | Sugiyama | ACTN4 | WKDGLAFNALIHRHRPELIEyDKLRKDDPVTNLNNAFEVAE |
| O43707 | Y234 | Sugiyama | ACTN4 | KLRKDDPVTNLNNAFEVAEKyLDIPKMLDAEDIVNtARPDE |
| O43707 | Y397 | Sugiyama | ACTN4 | GKMVSDINNGWQHLEQAEKGyEEWLLNEIRRLERLDHLAEK |
| O43707 | Y441 | Sugiyama | ACTN4 | KAsIHEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEs |
| O43707 | Y533 | Sugiyama | ACTN4 | REALEKTEKQLEAIDQLHLEyAKRAAPFNNWMESAMEDLQD |
| O43707 | Y878 | Sugiyama | ACTN4 | DKNFITAEELRRELPPDQAEyCIARMAPyQGPDAVPGALDy |
| O43765 | Y195 | Sugiyama | SGTA SGT SGT1 | HVEAVAYYKKALELDPDNEtyKsNLKIAELKLREAPSPTGG |
| O43776 | Y45 | Sugiyama | NARS1 NARS NRS | PFKTGLKALMTVGKEPFPtIyVDsQKENERWNVISKsQLKN |
| O43823 | Y311 | Sugiyama | AKAP8 AKAP95 | RGFDRFGPDGTGRKRKQFQLyEEPDtKLARVDsEGDFsEND |
| O43852 | Y106 | Sugiyama | CALU | GFVtVDELKDWIKFAQKRWIyEDVERQWKGHDLNEDGLVsW |
| O43852 | Y185 | Sugiyama | CALU | KDGDLIATKEEFtAFLHPEEyDyMKDIVVQEtMEDIDKNAD |
| O43852 | Y263 | Sugiyama | CALU | KNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNKDG |
| O43852 | Y47 | Sugiyama | CALU | RVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQLtPE |
| O43865 | Y28 | Sugiyama | AHCYL1 DCAL IRBIT XPVKONA | PLPGVGEELKQAKEIEDAEKysFMATVTKAPKKQIQFADDM |
| O43865 | Y291 | Sugiyama | AHCYL1 DCAL IRBIT XPVKONA | LCVPAMNVNDSVTKQKFDNLyCCRESILDGLKRTTDVMFGG |
| O60361 | Y136 | Sugiyama | NME2P1 | SLRFKPEELVDYKSCAHDWVyE___________________ |
| O60506 | Y133 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O60506 | Y293 | Sugiyama | SYNCRIP HNRPQ NSAP1 | VILyHQPDDKKKNRGFCFLEyEDHKTAAQARRRLMSGKVKV |
| O60506 | Y373 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ILEKAFsQFGKLERVKKLKDyAFIHFDERDGAVKAMEEMNG |
| O60506 | Y47 | Sugiyama | SYNCRIP HNRPQ NSAP1 | FQTLLDAGLPQKVAEKLDEIyVAGLVAHsDLDERAIEALKE |
| O60664 | Y95 | Sugiyama | PLIN3 M6PRBP1 TIP47 | VsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQQPTE |
| O60716 | Y228 | Sugiyama | CTNND1 KIAA0384 | yPPDGysRHyEDGyPGGsDNyGsLsRVtRIEERyRPsMEGy |
| O60814 | Y38 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| O60814 | Y41 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| O60814 | Y43 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| O60841 | Y134 | Sugiyama | EIF5B IF2 KIAA0741 | EELEDKDsKSKKTAKPKVEMysGsDDDDDFNKLPKKAKGKA |
| O75116 | S724 | Sugiyama | ROCK2 KIAA0619 | EEAEHKATKARLADKNKIyEsIEEAKSEAMKEMEKKLLEER |
| O75116 | Y722 | Sugiyama | ROCK2 KIAA0619 | EQEEAEHKATKARLADKNKIyEsIEEAKSEAMKEMEKKLLE |
| O75116 | Y936 | Sugiyama | ROCK2 KIAA0619 | EITLTKADSEQLARsIAEEQysDLEKEKIMKELEIKEMMAR |
| O75208 | Y93 | Sugiyama | COQ9 C16orf49 HSPC326 PSEC0129 | PEssHsPPRYTDQGGEEEEDyEsEEQLQHRILTAALEFVPA |
| O75347 | Y75 | Sugiyama | TBCA | EILQEsRMMIPDCQRRLEAAyLDLQRILENEKDLEEAEEyK |
| O75533 | Y44 | Sugiyama | SF3B1 SAP155 | ALDEAQGVGLDstGYyDQEIyGGSDSRFAGYVtSIAAtELE |
| O75534 | S598 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | KVNKtHsVNGItEEADPTIysGKVIRPLRSVDPTQTEYQGM |
| O75534 | Y597 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | EKVNKtHsVNGItEEADPTIysGKVIRPLRSVDPTQTEYQG |
| O75688 | Y367 | Sugiyama | PPM1B PP2CB | IPNLPPGGGLAGKRNVIEAVySRLNPHREsDGAsDEAEEsG |
| O75817 | Y38 | Sugiyama | POP7 RPP20 | VEytLRKRLPSRLPRRPNDIyVNMKTDFKAQLARCQKLLDG |
| O75874 | Y391 | Sugiyama | IDH1 PICD | FMTKDLAACIKGLPNVQRsDyLNTFEFMDKLGENLKIKLAQ |
| O75976 | Y1376 | Sugiyama | CPD | KKsLLsHEFQDEtDtEEEtLyssKH________________ |
| O94906 | Y105 | Sugiyama | PRPF6 C20orf14 | AGSLFSSGPYEKDDEEADAIyAALDKRMDERRKERREQREK |
| O95218 | Y114 | Sugiyama | ZRANB2 ZIS ZNF265 | AKLEERtGYGGGFNERENVEyIEREEsDGEyDEFGRKKKKY |
| O95297 | Y263 | Sugiyama | MPZL1 PZR UNQ849/PRO1787 | QLDHsGGHHSDKINKSEsVVyADIRKN______________ |
| O95347 | Y938 | Sugiyama | SMC2 CAPE SMC2L1 PRO0324 | SKHKREAEDGAAKVSKMLKDyDWINAERHLFGQPNSAYDFK |
| O95453 | S557 | Sugiyama | PARN DAN | KRLNPQCIPYTLQNHYYRNNsFtAPstVGKRNLsPsQEEAG |
| O95453 | T559 | Sugiyama | PARN DAN | LNPQCIPYTLQNHYYRNNsFtAPstVGKRNLsPsQEEAGLE |
| O95456 | Y287 | Sugiyama | PSMG1 C21LRP DSCR2 PAC1 | PQSTEILKKLMTTNEIQsNIyt___________________ |
| O95757 | Y600 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | IDLPIQssLCRQLGQDLLNsyIENEGKMIMQDKLEKERNDA |
| O95757 | Y629 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | MQDKLEKERNDAKNAVEEyVyDFRDRLGtVYEKFITPEDLS |
| O95861 | Y293 | Sugiyama | BPNT1 | HKDVKHMNSAGVLAtLRNyDyyASRVPESIKNALVP_____ |
| O96019 | Y69 | Sugiyama | ACTL6A BAF53 BAF53A INO80K | DGsTLMEIDGDKGKQGGPtyyIDtNALRVPRENMEAIsPLK |
| P00338 | Y10 | Sugiyama | LDHA PIG19 | ___________MAtLKDQLIyNLLKEEQtPQNKITVVGVGA |
| P00338 | Y239 | Sugiyama | LDHA PIG19 | GtDKDKEQWKEVHKQVVEsAyEVIKLKGYtSWAIGLSVADL |
| P00390 | Y371 | Sugiyama | GSR GLUR GRD1 | TDDKGHIIVDEFQNtNVKGIyAVGDVCGKALLtPVAIAAGR |
| P00491 | Y166 | Sugiyama | PNP NP | PLRGPNDERFGDRFPAMsDAyDRtMRQRALstWKQMGEQRE |
| P00505 | Y96 | Sugiyama | GOT2 KYAT4 | VLPSVRKAEAQIAAKNLDKEyLPIGGLAEFCKASAELALGE |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P00558 | Y196 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | MVGVNLPQKAGGFLMKKELNyFAKALEsPERPFLAILGGAK |
| P00966 | Y163 | Sugiyama | ASS1 ASS | APWRMPEFYNRFKGRNDLMEyAKQHGIPIPVtPKNPWSMDE |
| P02545 | Y45 | Sugiyama | LMNA LMN1 | RItRLQEKEDLQELNDRLAVyIDRVRsLETENAGLRLRItE |
| P02786 | Y168 | Sugiyama | TFRC | NENsyVPREAGsQKDENLALyVENQFREFKLSKVWRDQHFV |
| P02786 | Y402 | Sugiyama | TFRC | KEIKILNIFGVIKGFVEPDHyVVVGAQRDAWGPGAAKSGVG |
| P04040 | Y447 | Sugiyama | CAT | GEVRRFNtANDDNVtQVRAFyVNVLNEEQRKRLCENIAGHL |
| P04181 | Y69 | Sugiyama | OAT | KyGAHNyHPLPVALERGKGIyLWDVEGRKYFDFLSSYSAVN |
| P04406 | Y314 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | tFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsK |
| P04406 | Y320 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE_____ |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04818 | Y135 | Sugiyama | TYMS TS OK/SW-cl.29 | RDFLDsLGFsTREEGDLGPVyGFQWRHFGAEyRDMEsDysG |
| P05198 | Y150 | Sugiyama | EIF2S1 EIF2A | LFQRTAWVFDDKyKRPGyGAyDAFKHAVsDPsILDsLDLNE |
| P05362 | T454 | Sugiyama | ICAM1 | DGtFPLPIGEsVtVtRDLEGtyLCRARSTQGEVTRKVTVNV |
| P05787 | Y204 | Sugiyama | KRT8 CYK8 | NKRTEMENEFVLIKKDVDEAyMNKVELESRLEGLTDEINFL |
| P05787 | Y282 | Sugiyama | KRT8 CYK8 | EVKAQyEDIANRsRAEAEsMyQIKyEELQsLAGKHGDDLRR |
| P06493 | Y15 | Sugiyama | CDK1 CDC2 CDC28A CDKN1 P34CDC2 | ______MEDyTKIEKIGEGtyGVVyKGRHKTTGQVVAMKKI |
| P06733 | S268 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | ASEFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyP |
| P06733 | T41 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKG |
| P06733 | Y189 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | MILPVGAANFREAMRIGAEVyHNLKNVIKEKyGKDAtNVGD |
| P06733 | Y270 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVV |
| P06733 | Y280 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | DFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDD |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P06899 | Y38 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | AVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSK |
| P06899 | Y41 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | KAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKAMG |
| P06899 | Y43 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | QKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKAMGIM |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07205 | Y196 | Sugiyama | PGK2 PGKB | MVGVNLPHKASGFLMKKELDyFAKALENPVRPFLAILGGAK |
| P07237 | Y94 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPK |
| P07355 | Y188 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | RKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVKRKGT |
| P07355 | Y199 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | RAEDGsVIDyELIDQDARDLyDAGVKRKGTDVPKWIsIMTE |
| P07437 | T107 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKEAESC |
| P07437 | Y106 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | RPDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKEAES |
| P07437 | Y50 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | IDPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEP |
| P07437 | Y51 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | DPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPG |
| P07686 | Y547 | Sugiyama | HEXB HCC7 | DRLTRHRCRMVERGIAAQPLyAGyCNHENM___________ |
| P07711 | Y112 | Sugiyama | CTSL CTSL1 | MNGFQNRKPRKGKVFQEPLFyEAPRSVDWREKGyVTPVKNQ |
| P07737 | Y129 | Sugiyama | PFN1 | tLVLLMGKEGVHGGLINKKCyEMAsHLRRsQY_________ |
| P07741 | Y60 | Sugiyama | APRT | RAAIGLLARHLKATHGGRIDyIAGLDsRGFLFGPSLAQELG |
| P07814 | Y1504 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | KPLCELQPGAKCVCGKNPAKyytLFGRsy____________ |
| P07814 | Y1505 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PLCELQPGAKCVCGKNPAKyytLFGRsy_____________ |
| P07814 | Y827 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EIGQNIssNssAsILESKsLyDEVAAQGEVVRKLKAEKSPK |
| P07858 | Y244 | Sugiyama | CTSB CPSB | HYGYNSYSVSNSEKDIMAEIyKNGPVEGAFSVYSDFLLYKS |
| P07900 | Y160 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | SAYLVAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPM |
| P07900 | Y284 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEEEEKKDGDKKKKKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P07900 | Y309 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHF |
| P07900 | Y313 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P07900 | Y492 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLR |
| P07900 | Y493 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLRK |
| P07900 | Y61 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KEIFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLI |
| P07954 | Y54 | Sugiyama | FH | PSFWPPNAARMAsQNSFRIEyDtFGELKVPNDKYYGAQTVR |
| P08238 | Y155 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | SAYLVAEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPI |
| P08238 | Y276 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08238 | Y305 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P08238 | Y430 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KKCLELFsELAEDKENyKKFyEAFSKNLKLGIHEDstNRRR |
| P08238 | Y472 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEsKE |
| P08238 | Y484 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVR |
| P08238 | Y485 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVRK |
| P08238 | Y56 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEIFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDII |
| P08238 | Y619 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | TANMERIMKAQALRDNstMGyMMAKKHLEINPDHPIVEtLR |
| P08708 | Y84 | Sugiyama | RPS17 RPS17L | GPVRGISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKE |
| P08758 | Y91 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | SELTGKFEKLIVALMKPSRLyDAyELKHALKGAGTNEKVLt |
| P09104 | Y44 | Sugiyama | ENO2 | LyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKGVLK |
| P09211 | T62 | Sugiyama | GSTP1 FAEES3 GST3 | GsLKASCLyGQLPKFQDGDLtLyQsNtILRHLGRTLGLYGK |
| P09234 | T11 | Sugiyama | SNRPC | __________MPKFyCDyCDtyLtHDsPsVRKTHCSGRKHK |
| P09234 | T14 | Sugiyama | SNRPC | _______MPKFyCDyCDtyLtHDsPsVRKTHCSGRKHKENV |
| P09651 | Y341 | Sugiyama | HNRNPA1 HNRPA1 | QSSNFGPMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGss |
| P09651 | Y347 | Sugiyama | HNRNPA1 HNRPA1 | PMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGssssssyG |
| P09884 | Y414 | Sugiyama | POLA1 POLA | MKIDLNTGKEtGtPISMKDVyEEFDEKIATKYKIMKFKSKP |
| P09972 | Y358 | Sugiyama | ALDOC ALDC | AAQGKYEGSGEDGGAAAQsLyIANHAY______________ |
| P0CG38 | Y1062 | Sugiyama | POTEI | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0CG39 | Y1025 | Sugiyama | POTEJ | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0DPH7 | Y103 | Sugiyama | TUBA3C TUBA2 | yRQLFHPEQLItGKEDAANNyARGHYTIGKEIVDLVLDRIR |
| P0DPH7 | Y224 | Sugiyama | TUBA3C TUBA2 | VDNEAIYDICRRNLDIERPtytNLNRLIGQIVSSITASLRF |
| P10398 | Y155 | Sugiyama | ARAF ARAF1 PKS PKS2 | HCSSKVPTVCVDMSTNRQQFyHsVQDLsGGsRQHEAPsNRP |
| P10412 | Y71 | Sugiyama | H1-4 H1F4 HIST1H1E | SKERsGVsLAALKKALAAAGyDVEKNNSRIKLGLKsLVsKG |
| P10809 | Y243 | Sugiyama | HSPD1 HSP60 | yIsPyFINtsKGQKCEFQDAyVLLsEKKIssIQsIVPALEI |
| P11142 | S544 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KYKAEDEKQRDKVssKNsLEsyAFNMKATVEDEKLQGKIND |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P11142 | Y545 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | YKAEDEKQRDKVssKNsLEsyAFNMKATVEDEKLQGKINDE |
| P11310 | Y67 | Sugiyama | ACADM | EFQATARKFAREEIIPVAAEyDKTGEyPVPLIRRAWELGLM |
| P11413 | Y112 | Sugiyama | G6PD | PEEKLKLEDFFARNsyVAGQyDDAAsyQRLNsHMNALHLGs |
| P11498 | Y118 | Sugiyama | PC | HIPDIIKVAKENNVDAVHPGyGFLsERADFAQACQDAGVRF |
| P11940 | Y194 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLFGKF |
| P11940 | Y291 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | ERQTELKRKFEQMKQDRITRyQGVNLyVKNLDDGIDDERLR |
| P11940 | Y297 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KRKFEQMKQDRITRyQGVNLyVKNLDDGIDDERLRKEFsPF |
| P12268 | Y509 | Sugiyama | IMPDH2 IMPD2 | KFEKRtssAQVEGGVHsLHsyEKRLF_______________ |
| P12277 | Y125 | Sugiyama | CKB CKBB | EHKTDLNPDNLQGGDDLDPNyVLssRVRTGRSIRGFCLPPH |
| P12277 | Y39 | Sugiyama | CKB CKBB | EFPDLSAHNNHMAKVLtPELyAELRAKSTPSGFTLDDVIQT |
| P12814 | Y215 | Sugiyama | ACTN1 | KLRKDDPLTNLNTAFDVAEKyLDIPKMLDAEDIVGtARPDE |
| P12814 | Y378 | Sugiyama | ACTN1 | GRMVSDINNAWGCLEQVEKGyEEWLLNEIRRLERLDHLAEK |
| P12814 | Y422 | Sugiyama | ACTN1 | KAsIHEAWtDGKEAMLRQKDyEtAtLsEIKALLKKHEAFEs |
| P12814 | Y842 | Sugiyama | ACTN1 | DTDTADQVMASFKILAGDKNyITMDELRRELPPDQAEyCIA |
| P12814 | Y859 | Sugiyama | ACTN1 | DKNyITMDELRRELPPDQAEyCIARMAPYTGPDSVPGALDY |
| P12956 | Y103 | Sugiyama | XRCC6 G22P1 | LAVVFYGTEKDKNSVNFKNIyVLQELDNPGAKRILELDQFK |
| P13639 | S732 | Sugiyama | EEF2 EF2 | DAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCP |
| P13639 | T582 | Sugiyama | EEF2 EF2 | EEDHACIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKHNRL |
| P13639 | Y373 | Sugiyama | EEF2 EF2 | MITIHLPSPVTAQKyRCELLyEGPPDDEAAMGIKsCDPKGP |
| P13639 | Y443 | Sugiyama | EEF2 EF2 | TGLKVRIMGPNytPGKKEDLyLKPIQRTILMMGRYVEPIED |
| P13639 | Y634 | Sugiyama | EEF2 EF2 | AEDIDKGEVsARQELKQRARyLAEKyEWDVAEARKIWCFGP |
| P13639 | Y639 | Sugiyama | EEF2 EF2 | KGEVsARQELKQRARyLAEKyEWDVAEARKIWCFGPDGTGP |
| P13639 | Y671 | Sugiyama | EEF2 EF2 | CFGPDGTGPNILTDITKGVQyLNEIKDSVVAGFQWATKEGA |
| P13639 | Y730 | Sugiyama | EEF2 EF2 | HADAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQ |
| P13667 | Y392 | Sugiyama | PDIA4 ERP70 ERP72 | HMMDVQGstQDsAIKDFVLKyALPLVGHRKVSNDAKRYTRR |
| P13667 | Y458 | Sugiyama | PDIA4 ERP70 ERP72 | VLEVAKDFPEytFAIADEEDyAGEVKDLGLsEsGEDVNAAI |
| P13667 | Y565 | Sugiyama | PDIA4 ERP70 ERP72 | DVLIEFYAPWCGHCKQLEPVyNsLAKKYKGQKGLVIAKMDA |
| P13674 | Y141 | Sugiyama | P4HA1 P4HA | FPNDEDQVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKSF |
| P13674 | Y282 | Sugiyama | P4HA1 P4HA | ASDDQSDQKTTPKKKGVAVDyLPERQKyEMLCRGEGIKMTP |
| P13796 | Y462 | Sugiyama | LCP1 PLS2 | VNKPPYPKLGGNMKKLENCNyAVELGKNQAKFsLVGIGGQD |
| P13797 | Y465 | Sugiyama | PLS3 | VNKPPYPKLGANMKKLENCNyAVELGKHPAKFSLVGIGGQD |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P13929 | Y44 | Sugiyama | ENO3 | LHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKGVLK |
| P13987 | Y87 | Sugiyama | CD59 MIC11 MIN1 MIN2 MIN3 MSK21 | FEHCNFNDVtTRLRENELtyyCCKKDLCNFNEQLENGGTSL |
| P14314 | Y106 | Sugiyama | PRKCSH G19P1 | yIPSNRVNDGVCDCCDGtDEyNsGVICENtCKEKGRKEREs |
| P14314 | Y465 | Sugiyama | PRKCSH G19P1 | sLGtWGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLC |
| P14625 | Y401 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | VTFKSILFVPTSAPRGLFDEyGsKKSDYIKLYVRRVFITDD |
| P14625 | Y527 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | AKLLRFQssHHPtDItsLDQyVERMKEKQDKIyFMAGsSRK |
| P14625 | Y539 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDItsLDQyVERMKEKQDKIyFMAGsSRKEAEssPFVERLL |
| P14649 | S87 | Sugiyama | MYL6B MLC1SA | EEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVLK |
| P14649 | Y86 | Sugiyama | MYL6B MLC1SA | LEEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVL |
| P14868 | Y143 | Sugiyama | DARS1 DARS PIG40 | VNQKIGSCTQQDVELHVQKIyVISLAEPRLPLQLDDAVRPE |
| P15153 | Y154 | Sugiyama | RAC2 | LAPITYPQGLALAKEIDSVKyLECsALtQRGLKtVFDEAIR |
| P15259 | Y92 | Sugiyama | PGAM2 PGAMM | DGTDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEEQV |
| P15311 | Y424 | Sugiyama | EZR VIL2 | ERQAVDQIKsQEQLAAELAEytAKIALLEEARRRKEDEVEE |
| P15880 | Y248 | Sugiyama | RPS2 RPS4 | GCtAtLGNFAKATFDAISKTysyLtPDLWKEtVFtKsPyQE |
| P16402 | Y72 | Sugiyama | H1-3 H1F3 HIST1H1D | SKERsGVsLAALKKALAAAGyDVEKNNSRIKLGLKsLVsKG |
| P16403 | Y71 | Sugiyama | H1-2 H1F2 HIST1H1C | SKERsGVsLAALKKALAAAGyDVEKNNSRIKLGLKsLVsKG |
| P16410 | Y201 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | CTLA4 CD152 | LTAVSLSKMLKKRSPLTTGVyVKMPPTEPECEKQFQPyFIP |
| P17066 | Y43 | Sugiyama | HSPA6 HSP70B' | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P17844 | Y59 | Sugiyama | DDX5 G17P1 HELR HLR1 | EKLVKKKWNLDELPKFEKNFyQEHPDLARRtAQEVETYRRS |
| P17980 | Y185 | Sugiyama | PSMC3 TBP1 | PtEyDsRVKAMEVDERPtEQysDIGGLDKQIQELVEAIVLP |
| P17987 | Y545 | Sugiyama | TCP1 CCT1 CCTA | LRIDDLIKLHPESKDDKHGsyEDAVHsGALND_________ |
| P18124 | Y155 | Sugiyama | RPL7 | IVEPYIAWGYPNLKsVNELIyKRGYGKINKKRIALtDNALI |
| P18124 | Y82 | Sugiyama | RPL7 | RQMYRTEIRMARMARKAGNFyVPAEPKLAFVIRIRGINGVS |
| P18615 | Y133 | Sugiyama | NELFE RD RDBP | sIsADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEA |
| P18615 | Y170 | Sugiyama | NELFE RD RDBP | GEEAEGPGAGDGPPRsFDWGyEERSGAHSsAsPPRsRSRDR |
| P18615 | Y367 | Sugiyama | NELFE RD RDBP | SLAVQNsPKGCHRDKRTQIVysDDVyKENLVDGF_______ |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18669 | S137 | Sugiyama | PGAM1 PGAMA CDABP0006 | RsyDVPPPPMEPDHPFysNIsKDRRyADLtEDQLPsCEsLK |
| P18669 | Y133 | Sugiyama | PGAM1 PGAMA CDABP0006 | KIWRRsyDVPPPPMEPDHPFysNIsKDRRyADLtEDQLPsC |
| P18669 | Y142 | Sugiyama | PGAM1 PGAMA CDABP0006 | PPPPMEPDHPFysNIsKDRRyADLtEDQLPsCEsLKDtIAR |
| P18669 | Y26 | Sugiyama | PGAM1 PGAMA CDABP0006 | LVLIRHGEsAWNLENRFsGWyDADLsPAGHEEAKRGGQALR |
| P18669 | Y92 | Sugiyama | PGAM1 PGAMA CDABP0006 | DAIDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQV |
| P18754 | Y89 | Sugiyama | RCC1 CHC1 | VVQAEAGGMHTVCLSKsGQVysFGCNDEGALGRDtsVEGSE |
| P19105 | Y142 | Sugiyama | MYL12A MLCB MRLC3 RLC | LRELLttMGDRFtDEEVDELyREAPIDKKGNFNyIEFtRIL |
| P19105 | Y155 | Sugiyama | MYL12A MLCB MRLC3 RLC | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| P19174 | Y783 | GPS6|EPSD | PLCG1 PLC1 | KIGTAEPDyGALyEGRNPGFyVEANPMPTFKCAVKALFDYK |
| P19338 | Y462 | Sugiyama | NCL | AEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWs |
| P19838 | Y240 | Sugiyama | NFKB1 | LPDSTGSFTRRLEPVVSDAIyDSKAPNASNLKIVRMDRTAG |
| P20042 | Y176 | Sugiyama | EIF2S2 EIF2B | GIsFsNQtGPAWAGSERDytyEELLNRVFNIMREKNPDMVA |
| P20618 | Y150 | Sugiyama | PSMB1 PSC5 | FPYYVYNIIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSAS |
| P21127 | Y449 | Sugiyama | CDK11B CDC2L1 CDK11 PITSLREA PK58 | LQGCRsVEEFQCLNRIEEGtyGVVYRAKDKKTDEIVALKRL |
| P21980 | Y369 | Sugiyama | TGM2 | PGYEGWQALDPTPQEKsEGtyCCGPVPVRAIKEGDLstKyD |
| P22234 | Y22 | Sugiyama | PAICS ADE2 AIRC PAIS | AtAEVLNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAG |
| P22314 | Y451 | Sugiyama | UBA1 A1S9T UBE1 | CLPEDKEVLTEDKCLQRQNRyDGQVAVFGsDLQEKLGKQKY |
| P22314 | Y55 | Sugiyama | UBA1 A1S9T UBE1 | SVPTNGMAKNGsEADIDEGLysRQLyVLGHEAMKRLQTSSV |
| P22314 | Y560 | Sugiyama | UBA1 A1S9T UBE1 | NPHIRVTSHQNRVGPDtERIyDDDFFQNLDGVANALDNVDA |
| P22314 | Y60 | Sugiyama | UBA1 A1S9T UBE1 | GMAKNGsEADIDEGLysRQLyVLGHEAMKRLQTSSVLVSGL |
| P22392 | Y151 | Sugiyama | NME2 NM23B | SLWFKPEELVDyKSCAHDWVyE___________________ |
| P22492 | Y75 | Sugiyama | H1-6 H1FT H1T HIST1H1T | SQERVGMSLVALKKALAAAGyDVEKNNSRIKLSLKSLVNKG |
| P22626 | Y331 | Sugiyama | HNRNPA2B1 HNRPA2B1 | SNYGPMKsGNFGGsRNMGGPyGGGNyGPGGsGGsGGyGGRs |
| P22626 | Y336 | Sugiyama | HNRNPA2B1 HNRPA2B1 | MKsGNFGGsRNMGGPyGGGNyGPGGsGGsGGyGGRsRy___ |
| P23193 | Y126 | Sugiyama | TCEA1 GTF2S TFIIS | EsTSsGNVsNRKDETNARDTyVsSFPRAPstsDsVRLKCRE |
| P23246 | Y488 | Sugiyama | SFPQ PSF | PMYQKEREtPPRFAQHGtFEyEysQRWKsLDEMEKQQREQV |
| P23246 | Y490 | Sugiyama | SFPQ PSF | YQKEREtPPRFAQHGtFEyEysQRWKsLDEMEKQQREQVEK |
| P23258 | Y60 | Sugiyama | TUBG1 TUBG | FATEGTDRKDVFFyQADDEHyIPRAVLLDLEPRVIHSILNs |
| P23284 | Y119 | Sugiyama | PPIB CYPB | DFMIQGGDFtRGDGtGGKsIyGERFPDENFKLKHyGPGWVs |
| P23396 | Y34 | Sugiyama | RPS3 OK/SW-cl.26 | DGIFKAELNEFLtRELAEDGysGVEVRVtPTRTEIIILATR |
| P23434 | Y139 | Sugiyama | GCSH | EVTEINEALAENPGLVNKSCyEDGWLIKMtLsNPsELDELM |
| P23526 | Y165 | Sugiyama | AHCY SAHH | QLLPGIRGIsEEtTTGVHNLyKMMANGILKVPAINVNDsVt |
| P23526 | Y193 | Sugiyama | AHCY SAHH | LKVPAINVNDsVtKsKFDNLyGCRESLIDGIKRATDVMIAG |
| P23527 | Y38 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | AVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSK |
| P23527 | Y41 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | KAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKAMG |
| P23527 | Y43 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | QKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKAMGIM |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P23528 | Y140 | Sugiyama | CFL1 CFL | SKDAIKKKLtGIKHELQANCyEEVKDRCTLAEKLGGsAVIs |
| P23528 | Y68 | Sugiyama | CFL1 CFL | ILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAt |
| P23528 | Y82 | Sugiyama | CFL1 CFL | QtVDDPyAtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFI |
| P23528 | Y85 | Sugiyama | CFL1 CFL | DDPyAtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWA |
| P23528 | Y89 | Sugiyama | CFL1 CFL | AtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWAPESA |
| P23921 | Y556 | Sugiyama | RRM1 RR1 | yyGALEASCDLAKEQGPyEtyEGsPVsKGILQYDMWNVTPT |
| P24752 | Y214 | Sugiyama | ACAT1 ACAT MAT | GsCAENTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNE |
| P24752 | Y90 | Sugiyama | ACAT1 ACAT MAT | IAIQGAIEKAGIPKEEVKEAyMGNVLQGGEGQAPTRQAVLG |
| P24941 | Y15 | Sugiyama | CDK2 CDKN2 | ______MENFQKVEKIGEGtyGVVyKARNKLTGEVVALKKI |
| P25205 | Y32 | Sugiyama | MCM3 | LREAQRDyLDFLDDEEDQGIyQsKVRELIsDNQyRLIVNVN |
| P25205 | Y456 | Sugiyama | MCM3 | AGIHARLNARCsVLAAANPVyGRyDQyKTPMENIGLQDSLL |
| P25398 | Y127 | Sugiyama | RPS12 | sCVVVKDYGKESQAKDVIEEyFKCKK_______________ |
| P25685 | Y176 | Sugiyama | DNAJB1 DNAJ1 HDJ1 HSPF1 | ARKKQDPPVTHDLRVsLEEIysGCtKKMKISHKRLNPDGKS |
| P25685 | Y52 | Sugiyama | DNAJB1 DNAJ1 HDJ1 HSPF1 | HPDKNKEPGAEEKFKEIAEAyDVLSDPRKREIFDRYGEEGL |
| P25786 | Y6 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | _______________MFRNQyDNDVtVWsPQGRIHQIEYAM |
| P26196 | Y469 | Sugiyama | DDX6 HLR2 RCK | IEEQLGTEIKPIPsNIDKSLyVAEyHsEPVEDEKP______ |
| P26196 | Y473 | Sugiyama | DDX6 HLR2 RCK | LGTEIKPIPsNIDKSLyVAEyHsEPVEDEKP__________ |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26599 | Y127 | Sugiyama | PTBP1 PTB | ANTMVNYYTSVTPVLRGQPIyIQFsNHKELKtDSSPNQARA |
| P26639 | T56 | Sugiyama | TARS1 TARS | KEGsGDGGRAELNPWPEyIytRLEMYNILKAEHDsILAEKA |
| P26639 | Y252 | Sugiyama | TARS1 TARS | YNKFKCRILNEKVNtPtttVyRCGPLIDLCRGPHVRHTGKI |
| P26639 | Y575 | Sugiyama | TARS1 TARS | YHQCATIQLDFQLPIRFNLtyVsHDGDDKKRPVIVHRAILG |
| P26639 | Y633 | Sugiyama | TARS1 TARS | PFWLSPRQVMVVPVGPtCDEyAQKVRQQFHDAKFMADIDLD |
| P26885 | Y112 | Sugiyama | FKBP2 FKBP13 | GLLGMCEGEKRKLVIPsELGyGERGAPPKIPGGATLVFEVE |
| P27348 | Y149 | Sugiyama | YWHAQ | LAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHPIRLG |
| P27348 | Y48 | Sugiyama | YWHAQ | AVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSIEQK |
| P27695 | Y128 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | LQELPGLSHQYWSAPsDKEGysGVGLLsRQCPLKVsyGIGD |
| P27695 | Y144 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | DKEGysGVGLLsRQCPLKVsyGIGDEEHDQEGRVIVAEFDS |
| P27695 | Y45 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | KSKTAAKKNDKEAAGEGPALyEDPPDQKtsPsGKPAtLKIC |
| P27797 | Y109 | Sugiyama | CALR CRTC | QTLVVQFTVKHEQNIDCGGGyVKLFPNSLDQTDMHGDSEYN |
| P27824 | Y70 | Sugiyama | CANX | TAPPSSPKVTYKAPVPtGEVyFADsFDRGTLSGWILSKAKK |
| P28066 | Y185 | Sugiyama | PSMA5 | CDARAIGsAsEGAQssLQEVyHKSMTLKEAIKSSLIILKQV |
| P28074 | Y236 | Sugiyama | PSMB5 LMPX MB1 X | RRAIyQATYRDAysGGAVNLyHVREDGWIRVSsDNVADLHE |
| P29144 | Y1042 | Sugiyama | TPP2 | TEALRDLKIQWMTKLDSsDIyNELKEtyPNyLPLyVARLHQ |
| P29353 | Y427 | Sugiyama | SHC1 SHC SHCA | RKQMPPPPPCPGRELFDDPsyVNVQNLDKARQAVGGAGPPN |
| P29401 | S308 | Sugiyama | TKT | PPQEDAPsVDIANIRMPsLPsyKVGDKIATRKAYGQALAKL |
| P29401 | Y202 | Sugiyama | TKT | LDINRLGQsDPAPLQHQMDIyQKRCEAFGWHAIIVDGHSVE |
| P29401 | Y481 | Sugiyama | TKT | AANTKGICFIRTsRPENAIIyNNNEDFQVGQAKVVLKSKDD |
| P29692 | S162 | Sugiyama | EEF1D EF1D | AKKPAtPAEDDEDDDIDLFGsDNEEEDKEAAQLREERLRQY |
| P29692 | Y26 | Sugiyama | EEF1D EF1D | LAHEKIWFDKFKYDDAERRFyEQMNGPVAGAsRQENGAsVI |
| P30043 | T199 | Sugiyama | BLVRB FLR SCAN | HDLGHFMLRCLttDEyDGHstyPsHQyQ_____________ |
| P30085 | Y49 | Sugiyama | CMPK1 CMK CMPK UCK UMK UMPK | ytHLSAGELLRDERKNPDsQyGELIEKYIKEGKIVPVEITI |
| P30086 | S104 | Sugiyama | PEBP1 PBP PEBP | WHHFLVVNMKGNDIssGtVLsDyVGsGPPKGtGLHRyVWLV |
| P30086 | Y106 | Sugiyama | PEBP1 PBP PEBP | HFLVVNMKGNDIssGtVLsDyVGsGPPKGtGLHRyVWLVyE |
| P30086 | Y64 | Sugiyama | PEBP1 PBP PEBP | tQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREW |
| P30101 | Y100 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LAKVDCTANTNTCNKyGVsGyPtLKIFRDGEEAGAyDGPRt |
| P30101 | Y115 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | yGVsGyPtLKIFRDGEEAGAyDGPRtADGIVsHLKKQAGPA |
| P30101 | Y445 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KDPNIVIAKMDAtANDVPsPyEVRGFPtIyFsPANKKLNPK |
| P30101 | Y67 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LMLVEFFAPWCGHCKRLAPEyEAAAtRLKGIVPLAKVDCTA |
| P30101 | Y95 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KGIVPLAKVDCTANTNTCNKyGVsGyPtLKIFRDGEEAGAy |
| P30876 | Y845 | Sugiyama | POLR2B | QEEVFEKPTRETCQGMRHAIyDKLDDDGLIAPGVRVSGDDV |
| P31153 | Y242 | Sugiyama | MAT2A AMS2 MATA2 | LKEKVIKAVVPAKyLDEDtIyHLQPsGRFVIGGPQGDAGLt |
| P31327 | Y1450 | Sugiyama | CPS1 | GsIDLVINLPNNNTKFVHDNyVIRRTAVDSGIPLLTNFQVT |
| P31483 | Y10 | Sugiyama | TIA1 | ___________MEDEMPKTLyVGNLSRDVTEALILQLFSQI |
| P31943 | Y266 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | yNGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQst |
| P31946 | S212 | Sugiyama | YWHAB | SLAKTAFDEAIAELDtLNEEsyKDstLIMQLLRDNLtLWtS |
| P31946 | Y151 | Sugiyama | YWHAB | LsEVAsGDNKQTtVsNsQQAyQEAFEIsKKEMQPTHPIRLG |
| P31946 | Y21 | Sugiyama | YWHAB | MTMDKsELVQKAKLAEQAERyDDMAAAMKAVtEQGHELsNE |
| P31946 | Y50 | Sugiyama | YWHAB | AVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P31947 | Y19 | Sugiyama | SFN HME1 | __MERASLIQKAKLAEQAERyEDMAAFMKGAVEKGEELsCE |
| P31947 | Y48 | Sugiyama | SFN HME1 | GAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsIEQK |
| P31948 | Y354 | Sugiyama | STIP1 | DVLKKCQQAEKILKEQERLAyINPDLALEEKNKGNECFQKG |
| P31948 | Y41 | Sugiyama | STIP1 | DDALQCysEAIKLDPHNHVLysNRsAAyAKKGDYQKAyEDG |
| P31948 | Y476 | Sugiyama | STIP1 | DLDssCKEAADGYQRCMMAQyNRHDsPEDVKRRAMADPEVQ |
| P32119 | Y115 | Sugiyama | PRDX2 NKEFB TDPX1 | GLGPLNIPLLADVTRRLsEDyGVLKTDEGIAYRGLFIIDGK |
| P32929 | S61 | Sugiyama | CTH | ISLSTTFKQGAPGQHsGFEysRsGNPTRNCLEKAVAALDGA |
| P32969 | Y180 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | LIQQATTVKNKDIRKFLDGIyVsEKGtVQQADE________ |
| P33121 | Y693 | Sugiyama | ACSL1 FACL1 FACL2 LACS LACS1 LACS2 | TMKAKRPELRNYFRSQIDDLyStIKV_______________ |
| P33316 | Y167 | Sugiyama | DUT | PPMEKAVVKTDIQIALPsGCyGRVAPRSGLAAKHFIDVGAG |
| P33778 | Y38 | Sugiyama | H2BC3 H2BFF HIST1H2BB | AITKAQKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISSK |
| P33778 | Y41 | Sugiyama | H2BC3 H2BFF HIST1H2BB | KAQKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISSKAMG |
| P33778 | Y43 | Sugiyama | H2BC3 H2BFF HIST1H2BB | QKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISSKAMGIM |
| P33991 | Y193 | Sugiyama | MCM4 CDC21 | FIDPLAKEEENVGIDITEPLyMQRLGEINVIGEPFLNVNCE |
| P33991 | Y394 | Sugiyama | MCM4 CDC21 | AHNDLVDKVQPGDRVNVTGIyRAVPIRVNPRVSNVKSVYKT |
| P33992 | S405 | Sugiyama | MCM5 CDC46 | TAKSQLLKFVEKCsPIGVytsGKGSSAAGLtAsVMRDPssR |
| P33993 | Y102 | Sugiyama | MCM7 CDC47 MCM2 | QELLPQYKEREVVNKDVLDVyIEHRLMMEQRSRDPGMVRsP |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P34932 | S31 | Sugiyama | HSPA4 APG2 HSPH2 | QSCYVAVARAGGIETIANEysDRCtPACIsFGPKNRSIGAA |
| P34932 | Y30 | Sugiyama | HSPA4 APG2 HSPH2 | FQSCYVAVARAGGIETIANEysDRCtPACIsFGPKNRSIGA |
| P34932 | Y336 | Sugiyama | HSPA4 APG2 HSPH2 | RVEPPLRSVLEQTKLKKEDIyAVEIVGGATRIPAVKEKISK |
| P34932 | Y597 | Sugiyama | HSPA4 APG2 HSPH2 | VDLPIENQLLWQIDREMLNLyIENEGKMIMQDKLEKERNDA |
| P34932 | Y624 | Sugiyama | HSPA4 APG2 HSPH2 | MIMQDKLEKERNDAKNAVEEyVyEMRDKLSGEYEKFVSEDD |
| P34932 | Y626 | Sugiyama | HSPA4 APG2 HSPH2 | MQDKLEKERNDAKNAVEEyVyEMRDKLSGEYEKFVSEDDRN |
| P35080 | Y79 | Sugiyama | PFN2 | FFtNGLtLGAKKCSVIRDSLyVDGDCtMDIRTKsQGGEPTy |
| P35244 | Y99 | Sugiyama | RPA3 REPA3 RPA14 | ILCTSYVQFKEDSHPFDLGLyNEAVKIIHDFPQFYPLGIVQ |
| P35579 | Y11 | Sugiyama | MYH9 | __________MAQQAADKyLyVDKNFINNPLAQADWAAKKL |
| P35606 | Y354 | Sugiyama | COPB2 | EIKDGERLPLAVKDMGsCEIyPQtIQHNPNGRFVVVCGDGE |
| P35609 | Y385 | Sugiyama | ACTN2 | GKMVSDIAGAWQRLEQAEKGyEEWLLNEIRRLERLEHLAEK |
| P36578 | Y211 | Sugiyama | RPL4 RPL1 | AGKGKMRNRRRIQRRGPCIIyNEDNGIIKAFRNIPGITLLN |
| P36871 | Y476 | Sugiyama | PGM1 | GKQFSANDKVYtVEKADNFEysDPVDGsIsRNQGLRLIFTD |
| P37802 | Y192 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NVIGLQMGtNRGAsQAGMtGyGMPRQIL_____________ |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P38646 | Y196 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | EtAENyLGHtAKNAVItVPAyFNDsQRQAtKDAGQIsGLNV |
| P39019 | Y48 | Sugiyama | RPS19 | LKVPEWVDtVKLAKHKELAPyDENWFytRAAstARHLYLRG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P40261 | Y11 | Sugiyama | NNMT | __________MESGFTSKDTyLSHFNPRDYLEKYYKFGSRH |
| P40429 | Y149 | Sugiyama | RPL13A | LKPTRKFAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYR |
| P40925 | Y210 | Sugiyama | MDH1 MDHA | tQYPDVNHAKVKLQGKEVGVyEALKDDsWLKGEFVttVQQR |
| P40939 | Y637 | Sugiyama | HADHA HADH | ELLTQMVSKGFLGRKSGKGFyIyQEGVKRKDLNSDMDSILA |
| P40939 | Y639 | Sugiyama | HADHA HADH | LTQMVSKGFLGRKSGKGFyIyQEGVKRKDLNSDMDSILASL |
| P42681 | S305 | Sugiyama | TXK PTK4 RLK | VHLGEWRSHIQVAIKAINEGsMSEEDFIEEAKVMMKLSHSK |
| P42681 | S422 | Sugiyama | TXK PTK4 RLK | CIVKISDFGMTRyVLDDEyVsSFGAKFPIKWSPPEVFLFNK |
| P42681 | Y330 | Sugiyama | TXK PTK4 RLK | DFIEEAKVMMKLSHSKLVQLyGVCIQRKPLYIVTEFMENGC |
| P42681 | Y380 | Sugiyama | TXK PTK4 RLK | GKLRKEMLLSVCQDICEGMEyLERNGYIHRDLAARNCLVSS |
| P42681 | Y414 | Sugiyama | TXK PTK4 RLK | RNCLVSSTCIVKISDFGMTRyVLDDEyVsSFGAKFPIKWSP |
| P42681 | Y420 | GPS6|EPSD|PSP|Sugiyama | TXK PTK4 RLK | STCIVKISDFGMTRyVLDDEyVsSFGAKFPIKWSPPEVFLF |
| P42681 | Y91 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | TXK PTK4 RLK | PLPPLPPSEVAEEKIQVKALyDFLPREPCNLALRRAEEYLI |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43243 | Y202 | Sugiyama | MATR3 KIAA0723 | RHFRRDsFDDRGPsLNPVLDyDHGsRsQEsGyyDRMDyEDD |
| P43243 | Y214 | Sugiyama | MATR3 KIAA0723 | PsLNPVLDyDHGsRsQEsGyyDRMDyEDDRLRDGERCRDDs |
| P43490 | Y34 | Sugiyama | NAMPT PBEF PBEF1 | ATDSYKVTHYKQYPPNTSKVysyFECREKKTENSKLRKVKY |
| P46777 | Y207 | Sugiyama | RPL5 MSTP030 | sKEFNAEVHRKHIMGQNVADyMRyLMEEDEDAyKKQFsQyI |
| P46777 | Y226 | Sugiyama | RPL5 MSTP030 | DyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAHAA |
| P46777 | Y240 | Sugiyama | RPL5 MSTP030 | KKQFsQyIKNsVtPDMMEEMyKKAHAAIRENPVyEKKPKKE |
| P46777 | Y253 | Sugiyama | RPL5 MSTP030 | PDMMEEMyKKAHAAIRENPVyEKKPKKEVKKKRWNRPKMsL |
| P46778 | T29 | Sugiyama | RPL21 | RGTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQ |
| P46778 | Y30 | Sugiyama | RPL21 | GTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQK |
| P46940 | Y1095 | Sugiyama | IQGAP1 KIAA0051 | VVKEIMDDKSLNIKTDPVDIyKsWVNQMESQTGEASKLPyD |
| P46940 | Y140 | Sugiyama | IQGAP1 KIAA0051 | LNAMDEIGLPKIFYPETTDIyDRKNMPRCIYCIHALSLYLF |
| P46940 | Y1478 | Sugiyama | IQGAP1 KIAA0051 | KIQTGLKKLTELGtVDPKNKyQELINDIARDIRNQRRYRQR |
| P47224 | Y114 | Sugiyama | RABIF MSS4 RASGRF3 | CADCEIGPIGWHCLDDKNSFyVALERVSHE___________ |
| P47712 | Y535 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | sFDDDELDAAVADPDEFERIyEPLDVKSKKIHVVDSGLTFN |
| P47756 | Y232 | Sugiyama | CAPZB | NIGRLVEDMENKIRstLNEIyFGKTKDIVNGLRSVQTFADK |
| P47914 | Y98 | Sugiyama | RPL29 | PKEVKPKIPKGVSRKLDRLAyIAHPKLGKRARARIAKGLRL |
| P48556 | Y225 | Sugiyama | PSMD8 | VAEFHTELERLPAKDIQTNVyIKHPVSLEQYLMEGSYNKVF |
| P48637 | Y375 | Sugiyama | GSS | LAAPSRFVLKPQREGGGNNLyGEEMVQALKQLKDSEERAsy |
| P48741 | Y43 | Sugiyama | HSPA7 HSP70B | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P49023 | Y88 | Sugiyama | PXN | QWQPSSSRFIHQQPQsssPVyGssAKtssVsNPQDsVGsPC |
| P49207 | Y32 | Sugiyama | RPL34 | sYNtASNKTRLSRTPGNRIVyLytKKVGKAPKSACGVCPGR |
| P49207 | Y34 | Sugiyama | RPL34 | NtASNKTRLSRTPGNRIVyLytKKVGKAPKSACGVCPGRLR |
| P49321 | Y540 | Sugiyama | NASP | DMLDLAKIIFKRQETKEAQLyAAQAHLKLGEVSVESENYVQ |
| P49327 | S286 | Sugiyama | FASN FAS | GDIQEQLIRSLyQsAGVAPEsFEyIEAHGtGTKVGDPQELN |
| P49327 | Y2034 | Sugiyama | FASN FAS | DYFVVFSSVSCGRGNAGQsNyGFANsAMERICEKRRHEGLP |
| P49327 | Y45 | Sugiyama | FASN FAS | NLIGGVDMVTDDDRRWKAGLyGLPRRsGKLKDLSRFDAsFF |
| P49736 | Y137 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | MRQRDREAGRGLGRMRRGLLyDsDEEDEERPARKRRQVERA |
| P49736 | Y234 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | VFKERIsDMCKENREsLVVNyEDLAAREHVLAYFLPEAPAE |
| P50395 | T408 | Sugiyama | GDI2 RABGDIB | VPKDLGtEsQIFIsRTyDAttHFEttCDDIKNIYKRMtGsE |
| P50395 | Y203 | Sugiyama | GDI2 RABGDIB | DFTGHALALYRtDDyLDQPCyEtINRIKLYsEsLARYGKsP |
| P50454 | Y135 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | LRSLSNSTARNVTWKLGsRLyGPssVsFADDFVRssKQHYN |
| P50897 | T265 | Sugiyama | PPT1 CLN1 PPT | GFYRsGQAKEtIPLQEtsLytQDRLGLKEMDNAGQLVFLAT |
| P50897 | Y264 | Sugiyama | PPT1 CLN1 PPT | FGFYRsGQAKEtIPLQEtsLytQDRLGLKEMDNAGQLVFLA |
| P50990 | Y30 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | GFAQMLKEGAKHFsGLEEAVyRNIQACKELAQTTRTAYGPN |
| P50995 | Y365 | Sugiyama | ANXA11 ANX11 | NRDESTNVDMSLAQRDAQELyAAGENRLGTDESKFNAVLCS |
| P50995 | Y482 | Sugiyama | ANXA11 ANX11 | sEtDLLDIRSEYKRMYGKsLyHDISGDtsGDyRKILLKICG |
| P51116 | Y614 | Sugiyama | FXR2 FMR1L2 | RGNRtDGsIsGDRQPVtVADyIsRAEsQsRQRPPLERTKPs |
| P51452 | Y38 | Sugiyama | DUSP3 VHR | DGSGCYsLPSQPCNEVTPRIyVGNAsVAQDIPKLQKLGITH |
| P51812 | Y707 | Sugiyama | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | QYQLNRQDAPHLVKGAMAAtysALNRNQsPVLEPVGRsTLA |
| P51965 | Y77 | Sugiyama | UBE2E1 UBCH6 | ADITLDPPPNCSAGPKGDNIyEWRSTILGPPGSVYEGGVFF |
| P52272 | Y681 | Sugiyama | HNRNPM HNRPM NAGR1 | PFDFTWKMLKDKFNECGHVLyADIKMENGKSKGCGVVKFEs |
| P52565 | Y156 | Sugiyama | ARHGDIA GDIA1 | GVKIDKtDyMVGsYGPRAEEyEFLtPVEEAPKGMLARGsYs |
| P52597 | Y266 | Sugiyama | HNRNPF HNRPF | ySGLSDGYGFTTDLFGRDLsyCLsGMyDHRYGDsEFtVQsT |
| P52888 | Y576 | Sugiyama | THOP1 | VLAKVDQALHTQTDADPAEEyARLCQEILGVPATPGTNMPA |
| P53621 | S730 | Sugiyama | COPA | TGNLEKLRKMMKIAEIRKDMsGHyQNALyLGDVSERVRILK |
| P53621 | Y569 | Sugiyama | COPA | IKYAVTTGDHGIIRTLDLPIyVTRVKGNNVyCLDRECRPRV |
| P53621 | Y738 | Sugiyama | COPA | KMMKIAEIRKDMsGHyQNALyLGDVSERVRILKNCGQKsLA |
| P54105 | Y38 | Sugiyama | CLNS1A CLCI ICLN | RQQPDTEAVLNGKGLGtGtLyIAEsRLSWLDGsGLGFSLEY |
| P54136 | Y323 | Sugiyama | RARS1 RARS | DITKAWKLICDVSRQELNKIyDALDVsLIERGEsFYQDRMN |
| P54577 | Y289 | Sugiyama | YARS1 YARS | FPLKSEFVILRDEKWGGNKTytAyVDLEKDFAAEVVHPGDL |
| P54577 | Y292 | Sugiyama | YARS1 YARS | KSEFVILRDEKWGGNKTytAyVDLEKDFAAEVVHPGDLKNS |
| P54577 | Y388 | Sugiyama | YARS1 YARS | LDIRVGKIITVEKHPDADsLyVEKIDVGEAEPRTVVSGLVQ |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P55060 | Y278 | Sugiyama | CSE1L CAS XPO2 | EEEAGLLELLKSQICDNAALyAQKyDEEFQRYLPRFVTAIW |
| P55060 | Y369 | Sugiyama | CSE1L CAS XPO2 | VPNMEFRAADEEAFEDNsEEyIRRDLEGsDIDTRRRAACDL |
| P55209 | Y106 | Sugiyama | NAP1L1 NRP | VKCAQIEAKFyEEVHDLERKyAVLyQPLFDKRFEIINAIYE |
| P55209 | Y110 | Sugiyama | NAP1L1 NRP | QIEAKFyEEVHDLERKyAVLyQPLFDKRFEIINAIYEPTEE |
| P55209 | Y66 | Sugiyama | NAP1L1 NRP | PQILAALQERLDGLVEtPtGyIEsLPRVVKRRVNALKNLQV |
| P55795 | Y266 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YGGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQst |
| P55884 | Y768 | Sugiyama | EIF3B EIF3S9 | ERRRTMMEDFRKYRKMAQELyMEQKNERLELRGGVDTDELD |
| P57053 | Y38 | Sugiyama | H2BC12L H2BFS H2BS1 | AVTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| P57053 | Y41 | Sugiyama | H2BC12L H2BFS H2BS1 | KAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P57053 | Y43 | Sugiyama | H2BC12L H2BFS H2BS1 | QKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P58876 | Y38 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| P58876 | Y41 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P58876 | Y43 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | Y209 | Sugiyama | TPI1 TPI | LRGWLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDG |
| P60228 | Y445 | Sugiyama | EIF3E EIF3S6 INT6 | KLNQNSRSEAPNWAtQDsGFy____________________ |
| P60660 | S30 | Sugiyama | MYL6 | AEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVLK |
| P60660 | Y29 | Sugiyama | MYL6 | TAEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVL |
| P60660 | Y86 | Sugiyama | MYL6 | DFEHFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMG |
| P60660 | Y89 | Sugiyama | MYL6 | HFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMGAEI |
| P60709 | Y198 | Sugiyama | ACTB | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60709 | Y294 | Sugiyama | ACTB | IHETTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQ |
| P60709 | Y362 | Sugiyama | ACTB | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P60763 | Y154 | Sugiyama | RAC3 | LAPITYPQGLAMAREIGSVKyLECsALtQRGLKtVFDEAIR |
| P60842 | Y197 | Sugiyama | EIF4A1 DDX2A EIF4A | KMFVLDEADEMLsRGFKDQIyDIFQKLNsNtQVVLLSATMP |
| P60842 | Y70 | Sugiyama | EIF4A1 DDX2A EIF4A | yGFEKPsAIQQRAILPCIKGyDVIAQAQsGtGKTATFAISI |
| P60900 | Y160 | Sugiyama | PSMA6 PROS27 | LIGIDEEQGPQVYKCDPAGyyCGFKATAAGVKQtEstsFLE |
| P60981 | Y85 | Sugiyama | DSTN ACTDP DSN | TDPFKHFVGMLPEKDCRyALyDAsFETKESRKEELMFFLWA |
| P61024 | Y7 | Sugiyama | CKS1B CKS1 PNAS-143 PNAS-16 | ______________MSHKQIyysDKyDDEEFEyRHVMLPKD |
| P61081 | Y172 | Sugiyama | UBE2M UBC12 | VLQNNRRLFEQNVQRSMRGGyIGstyFERCLK_________ |
| P61081 | Y177 | Sugiyama | UBE2M UBC12 | RRLFEQNVQRSMRGGyIGstyFERCLK______________ |
| P61247 | Y256 | Sugiyama | RPS3A FTE1 MFTL | sssGKAtGDEtGAKVERADGyEPPVQEsV____________ |
| P61247 | Y31 | Sugiyama | RPS3A FTE1 MFTL | KGGKKGAKKKVVDPFSKKDWyDVKAPAMFNIRNIGKTLVTR |
| P61313 | Y6 | Sugiyama | RPL15 EC45 TCBAP0781 | _______________MGAYKyIQELWRKKQSDVMRFLLRVR |
| P61353 | Y38 | Sugiyama | RPL27 | YSGRKAVIVKNIDDGtsDRPysHALVAGIDRyPRKVTAAMG |
| P61353 | Y75 | Sugiyama | RPL27 | AAMGKKKIAKRSKIKSFVKVyNyNHLMPtRysVDIPLDKtV |
| P61353 | Y77 | Sugiyama | RPL27 | MGKKKIAKRSKIKSFVKVyNyNHLMPtRysVDIPLDKtVVN |
| P61604 | T79 | Sugiyama | HSPE1 | EIQPVsVKVGDKVLLPEyGGtKVVLDDKDyFLFRDGDILGK |
| P61604 | Y76 | Sugiyama | HSPE1 | KGGEIQPVsVKVGDKVLLPEyGGtKVVLDDKDyFLFRDGDI |
| P61604 | Y88 | Sugiyama | HSPE1 | GDKVLLPEyGGtKVVLDDKDyFLFRDGDILGKyVD______ |
| P61758 | Y112 | Sugiyama | VBP1 PFDN3 | QKKKESTNSMETRFLLADNLyCKASVPPTDKVCLWLGANVM |
| P61978 | Y323 | Sugiyama | HNRNPK HNRPK | RARNLPLPPPPPPRGGDLMAyDRRGRPGDRYDGMVGFSADE |
| P61978 | Y72 | Sugiyama | HNRNPK HNRPK | KNAGAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISA |
| P61981 | S215 | Sugiyama | YWHAG | HLAKtAFDDAIAELDtLNEDsyKDstLIMQLLRDNLtLWts |
| P61981 | T31 | Sugiyama | YWHAG | ARLAEQAERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKN |
| P61981 | Y20 | Sugiyama | YWHAG | _MVDREQLVQKARLAEQAERyDDMAAAMKNVtELNEPLsNE |
| P61981 | Y49 | Sugiyama | YWHAG | NVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P62191 | Y184 | Sugiyama | PSMC1 | MDDTDPLVTVMKVEKAPQETyADIGGLDNQIQEIKESVELP |
| P62191 | Y439 | Sugiyama | PSMC1 | FKKSKENVLyKKQEGtPEGLyL___________________ |
| P62241 | Y117 | Sugiyama | RPS8 OK/SW-cl.83 | VKNCIVLIDStPYRQWyEsHyALPLGRKKGAKLtPEEEEIL |
| P62249 | Y115 | Sugiyama | RPS16 | YYQKYVDEASKKEIKDILIQyDRtLLVADPRRCESKKFGGP |
| P62249 | Y82 | Sugiyama | RPS16 | RFAGVDIRVRVKGGGHVAQIyAIRQSISKALVAYYQKYVDE |
| P62258 | Y152 | Sugiyama | YWHAE | LAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHPIRLG |
| P62258 | Y214 | Sugiyama | YWHAE | LAKAAFDDAIAELDtLsEEsyKDstLIMQLLRDNLtLWtsD |
| P62258 | Y49 | Sugiyama | YWHAE | KVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssIEQK |
| P62263 | S70 | Sugiyama | RPS14 PRO2640 | KETICRVTGGMKVKADRDEssPyAAMLAAQDVAQRCKELGI |
| P62263 | Y72 | Sugiyama | RPS14 PRO2640 | TICRVTGGMKVKADRDEssPyAAMLAAQDVAQRCKELGITA |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62269 | Y95 | Sugiyama | RPS18 D6S218E | RQYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLK |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62277 | Y18 | Sugiyama | RPS13 | ___MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVKEQIy |
| P62280 | Y55 | Sugiyama | RPS11 | RYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILsG |
| P62312 | Y72 | Sugiyama | LSM6 | VNGQLKNKyGDAFIRGNNVLyIstQKRRM____________ |
| P62633 | Y120 | Sugiyama | CNBP RNF163 ZNF9 | NCGKPGHLARDCDHADEQKCysCGEFGHIQKDCTKVKCYRC |
| P62714 | Y284 | Sugiyama | PPP2CB | NyCyRCGNQAAIMELDDTLKySFLQFDPAPRRGEPHVTRRT |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62750 | Y117 | Sugiyama | RPL23A | VFIVDVKANKHQIKQAVKKLyDIDVAKVNtLIRPDGEKKAY |
| P62750 | Y144 | Sugiyama | RPL23A | VNtLIRPDGEKKAYVRLAPDyDALDVANKIGII________ |
| P62750 | Y74 | Sugiyama | RPL23A | LRRQPKYPRKSAPRRNKLDHyAIIKFPLTTEsAMKKIEDNN |
| P62753 | Y156 | Sugiyama | RPS6 OK/SW-cl.2 | KRASRIRKLFNLsKEDDVRQyVVRKPLNKEGKKPRTKAPKI |
| P62805 | Y52 | Sugiyama | H4C1 H4/A H4FA HIST1H4A; H4C2 H4/I H4FI HIST1H4B; H4C3 H4/G H4FG HIST1H4C; H4C4 H4/B H4FB HIST1H4D; H4C5 H4/J H4FJ HIST1H4E; H4C6 H4/C H4FC HIST1H4F; H4C8 H4/H H4FH HIST1H4H; H4C9 H4/M H4FM HIST1H4I; H4C11 H4/E H4FE HIST1H4J; H4C12 H4/D H4FD HIST1H4K; H4C13 H4/K H4FK HIST1H4L; H4C14 H4/N H4F2 H4FN HIST2H4 HIST2H4A; H4C15 H4/O H4FO HIST2H4B; H4C16 H4-16 HIST4H4 | KPAIRRLARRGGVKRIsGLIyEETRGVLKVFLENVIRDAVt |
| P62807 | Y38 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | AVTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssK |
| P62807 | Y41 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P62807 | Y43 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | QKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P62826 | Y146 | Sugiyama | RAN ARA24 OK/SW-cl.81 | IKDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLAR |
| P62826 | Y147 | Sugiyama | RAN ARA24 OK/SW-cl.81 | KDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLARK |
| P62829 | Y38 | Sugiyama | RPL23 | LGLPVGAVINCADNTGAKNLyIIsVKGIKGRLNRLPAAGVG |
| P62847 | Y76 | Sugiyama | RPS24 | FVFGFRTHFGGGKttGFGMIyDsLDyAKKNEPKHRLARHGL |
| P62899 | Y108 | Sugiyama | RPL31 | LSRKRNEDEDsPNKLytLVtyVPVttFKNLQtVNVDEN___ |
| P62906 | Y11 | Sugiyama | RPL10A NEDD6 | __________MSSKVsRDtLyEAVREVLHGNQRKRRKFLET |
| P62913 | Y170 | Sugiyama | RPL11 | CIGAKHRISKEEAMRWFQQKyDGIILPGK____________ |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62937 | Y79 | Sugiyama | PPIA CYPA | GFMCQGGDFtRHNGTGGKsIyGEKFEDENFILKHtGPGILs |
| P62942 | Y27 | Sugiyama | FKBP1A FKBP1 FKBP12 | tIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRDRNKPF |
| P62979 | Y148 | Sugiyama | RPS27A UBA80 UBCEP1 | AGVFMAsHFDRHyCGKCCLtyCFNKPEDK____________ |
| P63000 | Y154 | Sugiyama | RAC1 TC25 MIG5 | LTPITYPQGLAMAKEIGAVKyLECsALtQRGLKtVFDEAIR |
| P63104 | Y149 | Sugiyama | YWHAZ | LAEVAAGDDKKGIVDQsQQAyQEAFEIsKKEMQPTHPIRLG |
| P63104 | Y19 | Sugiyama | YWHAZ | __MDKNELVQKAKLAEQAERyDDMAACMKsVtEQGAELsNE |
| P63104 | Y48 | Sugiyama | YWHAZ | sVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssIEQK |
| P63151 | Y74 | Sugiyama | PPP2R2A | IFQQEQENKIQSHSRGEyNVystFQsHEPEFDyLKSLEIEE |
| P63220 | Y53 | Sugiyama | RPS21 | QMNVAEVDKVTGRFNGQFKtyAICGAIRRMGEsDDsILRLA |
| P63261 | Y198 | Sugiyama | ACTG1 ACTG | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63261 | Y294 | Sugiyama | ACTG1 ACTG | IHETTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQ |
| P63261 | Y362 | Sugiyama | ACTG1 ACTG | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P67775 | Y284 | Sugiyama | PPP2CA | NyCyRCGNQAAIMELDDTLKySFLQFDPAPRRGEPHVTRRt |
| P67809 | Y196 | Sugiyama | YBX1 NSEP1 YB1 | sAPEGQAQQRRPyRRRRFPPyyMRRPYGRRPQysNPPVQGE |
| P67809 | Y197 | Sugiyama | YBX1 NSEP1 YB1 | APEGQAQQRRPyRRRRFPPyyMRRPYGRRPQysNPPVQGEV |
| P67809 | Y208 | Sugiyama | YBX1 NSEP1 YB1 | yRRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGE |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68104 | Y29 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68363 | Y103 | Sugiyama | TUBA1B | yRQLFHPEQLItGKEDAANNyARGHYTIGKEIIDLVLDRIR |
| P68363 | Y224 | Sugiyama | TUBA1B | VDNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLRF |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P68366 | Y103 | Sugiyama | TUBA4A TUBA1 | YRQLFHPEQLItGKEDAANNyARGHYTIGKEIIDPVLDRIR |
| P68366 | Y224 | Sugiyama | TUBA4A TUBA1 | VDNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLRF |
| P68400 | Y255 | Sugiyama | CSNK2A1 CK2A1 | GHDNYDQLVRIAKVLGTEDLyDyIDKYNIELDPRFNDILGR |
| P78316 | Y119 | Sugiyama | NOP14 C4orf9 NOL14 RES4-25 | EKMMKRFALEQQRHHEKKSIyNLNEDEELTHyGQsLADIEK |
| P78316 | Y130 | Sugiyama | NOP14 C4orf9 NOL14 RES4-25 | QRHHEKKSIyNLNEDEELTHyGQsLADIEKHNDIVDsDsDA |
| P84103 | Y13 | Sugiyama | SRSF3 SFRS3 SRP20 | ________MHRDsCPLDCKVyVGNLGNNGNKtELERAFGyy |
| P84103 | Y33 | Sugiyama | SRSF3 SFRS3 SRP20 | yVGNLGNNGNKtELERAFGyyGPLRSVWVARNPPGFAFVEF |
| P98082 | Y38 | Sugiyama | DAB2 DOC2 | AAPKAPsKKEKKKGPEKTDEyLLARFKGDGVKYKAKLIGID |
| Q00005 | Y70 | Sugiyama | PPP2R2B | IFQREQESKNQVHRRGEyNVystFQsHEPEFDyLKSLEIEE |
| Q00059 | Y165 | Sugiyama | TFAM TCF6 TCF6L2 | KKKELTLLGKPKRPRsAYNVyVAERFQEAKGDsPQEKLKTV |
| Q00169 | Y140 | Sugiyama | PITPNA PITPN | GTQENVHKLEPEAWKHVEAVyIDIADRSQVLSKDYKAEEDP |
| Q00341 | Y358 | Sugiyama | HDLBP HBP VGL | SETVILRGEPEKLGQALTEVyAKANsFTVSSVAAPSWLHRF |
| Q00526 | Y15 | Sugiyama | CDK3 CDKN3 | ______MDMFQKVEKIGEGtyGVVyKAKNRETGQLVALKKI |
| Q00610 | Y883 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | EARIHEGCEEPAtHNALAKIyIDsNNNPERFLRENPyyDsR |
| Q00839 | Y260 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | GDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVEEED |
| Q01085 | Y12 | Sugiyama | TIAL1 | _________MMEDDGQPRTLyVGNLSRDVTEVLILQLFSQI |
| Q01105 | Y146 | Sugiyama | SET | tEFEDIKsGyRIDFyFDENPyFENKVLSKEFHLNEsGDPss |
| Q01130 | Y44 | Sugiyama | SRSF2 SFRS2 | RtsPDtLRRVFEKYGRVGDVyIPRDRYTKESRGFAFVRFHD |
| Q01518 | T165 | Sugiyama | CAP1 CAP | AMAPKPGPYVKEMNDAAMFytNRVLKEYKDVDKKHVDWVKA |
| Q01518 | Y164 | Sugiyama | CAP1 CAP | VAMAPKPGPYVKEMNDAAMFytNRVLKEYKDVDKKHVDWVK |
| Q01581 | Y295 | Sugiyama | HMGCS1 HMGCS | LARMLLNDFLNDQNRDKNSIySGLEAFGDVKLEDTYFDRDV |
| Q02539 | Y74 | Sugiyama | H1-1 H1F1 HIST1H1A | SKERGGVSLAALKKALAAAGyDVEKNNSRIKLGIKsLVsKG |
| Q02878 | T118 | Sugiyama | RPL6 TXREB1 | GDKNGGTRVVKLRKMPRyyPtEDVPRKLLSHGKKPFSQHVR |
| Q02878 | Y116 | Sugiyama | RPL6 TXREB1 | VGGDKNGGTRVVKLRKMPRyyPtEDVPRKLLSHGKKPFSQH |
| Q04446 | Y657 | Sugiyama | GBE1 | RVGTALPGKFKIVLDSDAAEyGGHQRLDHSTDFFSEAFEHN |
| Q04837 | Y73 | Sugiyama | SSBP1 SSBP | PVTIFSLATNEMWRsGDsEVyQLGDVsQKTTWHRISVFRPG |
| Q04917 | Y49 | Sugiyama | YWHAH YWHA1 | AVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSIEQK |
| Q05639 | Y29 | Sugiyama | EEF1A2 EEF1AL STN | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| Q06830 | Y116 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | GLGPMNIPLVSDPKRtIAQDyGVLKADEGIsFRGLFIIDDK |
| Q06830 | Y34 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | NFKAtAVMPDGQFKDIsLsDyKGKYVVFFFYPLDFTFVCPT |
| Q08043 | Y229 | Sugiyama | ACTN3 | KLRKDDPIGNLNTAFEVAEKyLDIPKMLDAEDIVNtPKPDE |
| Q08378 | Y747 | Sugiyama | GOLGA3 | TLTQEALQSREQsLDALQTHyDELQARLGELQGEAASREDT |
| Q08J23 | Y51 | Sugiyama | NSUN2 SAKI TRM4 | EAGWEGGyPEIVKENKLFEHyyQELKIVPEGEWGQFMDALR |
| Q08J23 | Y52 | Sugiyama | NSUN2 SAKI TRM4 | AGWEGGyPEIVKENKLFEHyyQELKIVPEGEWGQFMDALRE |
| Q12931 | Y513 | Sugiyama | TRAP1 HSP75 HSPC5 | GtRNIyyLCAPNRHLAEHsPyyEAMKKKDTEVLFCFEQFDE |
| Q12931 | Y514 | Sugiyama | TRAP1 HSP75 HSPC5 | tRNIyyLCAPNRHLAEHsPyyEAMKKKDTEVLFCFEQFDEL |
| Q13017 | Y1109 | Sugiyama | ARHGAP5 RHOGAP5 | DNyAEPIDTIFKQKGYsDEIyVVPDDsQNRIKIRNsFVNNt |
| Q13094 | Y113 | SIGNOR|iPTMNet|EPSD | LCP2 | EETESHEEDNGGWSSFEEDDyESPNDDQDGEDDGDyEsPNE |
| Q13094 | Y128 | SIGNOR|iPTMNet|EPSD | LCP2 | FEEDDyESPNDDQDGEDDGDyEsPNEEEEAPVEDDADyEPP |
| Q13094 | Y145 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | LCP2 | DGDyEsPNEEEEAPVEDDADyEPPPSNDEEALQNSILPAKP |
| Q13151 | Y180 | Sugiyama | HNRNPA0 HNRPA0 | FHPIQGHRVEVKKAVPKEDIySGGGGGGsRSSRGGRGGRGR |
| Q13242 | Y17 | Sugiyama | SRSF9 SFRS9 SRP30C | ____MsGWADERGGEGDGRIyVGNLPTDVREKDLEDLFyKY |
| Q13242 | Y70 | Sugiyama | SRSF9 SFRS9 SRP30C | GLVPFAFVRFEDPRDAEDAIyGRNGyDYGQCRLRVEFPRTY |
| Q13263 | Y133 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | TVVDCPVCKQQCFSKDIVENyFMRDsGsKAATDAQDANQCC |
| Q13263 | Y242 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | ESCDTLTCRDCQLNAHKDHQyQFLEDAVRNQRKLLAsLVKR |
| Q13283 | Y19 | Sugiyama | G3BP1 G3BP | __MVMEKPsPLLVGREFVRQyytLLNQAPDMLHRFYGKNss |
| Q13283 | Y363 | Sugiyama | G3BP1 G3BP | FIGNLPHEVDKSELKDFFQsyGNVVELRINsGGKLPNFGFV |
| Q13310 | Y194 | Sugiyama | PABPC4 APP1 PABP4 | KSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELFsQF |
| Q13310 | Y297 | Sugiyama | PABPC4 APP1 PABP4 | KRKFEQLKQERISRyQGVNLyIKNLDDTIDDEKLRKEFsPF |
| Q13404 | Y145 | Sugiyama | UBE2V1 CROC1 UBE2V UEV1 P/OKcl.19 | RRLMMSKENMKLPQPPEGQCysN__________________ |
| Q13442 | S19 | Sugiyama | PDAP1 HASPP28 | __MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEEE |
| Q13442 | T18 | Sugiyama | PDAP1 HASPP28 | ___MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEE |
| Q13442 | Y17 | Sugiyama | PDAP1 HASPP28 | ____MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREE |
| Q13509 | T107 | Sugiyama | TUBB3 TUBB4 | PDNFIFGQSGAGNNWAKGHytEGAELVDsVLDVVRKECENC |
| Q13509 | Y106 | Sugiyama | TUBB3 TUBB4 | RPDNFIFGQSGAGNNWAKGHytEGAELVDsVLDVVRKECEN |
| Q13561 | Y207 | Sugiyama | DCTN2 DCTN50 | SKGGSGGKttGtPPDssLVtyELHsRPEQDKFSQAAKVAEL |
| Q13561 | Y6 | Sugiyama | DCTN2 DCTN50 | _______________MADPKyADLPGIARNEPDVYETSDLP |
| Q13561 | Y86 | Sugiyama | DCTN2 DCTN50 | GLDFsDRIGKTKRtGyEsGEyEMLGEGLGVKETPQQKYQRL |
| Q13573 | Y292 | Sugiyama | SNW1 SKIIP SKIP | GRGLQTVHINENFAKLAEALyIADRKAREAVEMRAQVERKM |
| Q13573 | Y430 | Sugiyama | SNW1 SKIIP SKIP | RLFNQSKGMDSGFAGGEDEIyNVyDQAWRGGKDMAQsIyRP |
| Q13615 | Y1023 | Sugiyama | MTMR3 KIAA0371 ZFYVE10 | ATssPDQPSRSHLDDDGMSVyTDTIQQRLRQIESGHQQEVE |
| Q13642 | Y149 | Sugiyama | FHL1 SLIM1 | CSNCKQVIGtGSFFPKGEDFyCVtCHETKFAKHCVKCNKAI |
| Q13765 | Y120 | Sugiyama | NACA HSD48 | KNILFVITKPDVYKSPAsDtyIVFGEAKIEDLsQQAQLAAA |
| Q13885 | T107 | Sugiyama | TUBB2A TUBB2 | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESESC |
| Q13885 | Y106 | Sugiyama | TUBB2A TUBB2 | RPDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESES |
| Q14152 | Y697 | Sugiyama | EIF3A EIF3S10 KIAA0139 | LEKEKKELQERLKNQEKKIDyFERAKRLEEIPLIKSAYEEQ |
| Q14157 | S859 | Sugiyama | UBAP2L KIAA0144 NICE4 | FPtPttPLtGRDGsLAsNPysGDLtKFGRGDASSPAPATTL |
| Q14194 | Y479 | Sugiyama | CRMP1 DPYSL1 ULIP3 | INVNKGMGRFIPRKAFPEHLyQRVKIRNKVFGLQGVSRGMY |
| Q14204 | Y2086 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | ANKIVPFFKLCDEQLSSQSHyDFGLRALKSVLVSAGNVKRE |
| Q14240 | Y71 | Sugiyama | EIF4A2 DDX2B EIF4F | yGFEKPsAIQQRAIIPCIKGyDVIAQAQsGtGKTATFAISI |
| Q14247 | Y421 | Sugiyama | CTTN EMS1 | tPPVsPAPQPtEERLPssPVyEDAAsFKAELsyRGPVsGtE |
| Q14257 | Y311 | Sugiyama | RCN2 ERC55 | NPDLFLtsEAtDyGRQLHDDyFyHDEL______________ |
| Q14257 | Y313 | Sugiyama | RCN2 ERC55 | DLFLtsEAtDyGRQLHDDyFyHDEL________________ |
| Q14258 | Y245 | Sugiyama | TRIM25 EFP RNF147 ZNF147 | NRQQDVRMTANRKVEQLQQEytEMKALLDASETTSTRKIKE |
| Q14566 | Y111 | Sugiyama | MCM6 | CRALKTFVKDRKEIPLAKDFyVAFQDLPTRHKIRELTSSRI |
| Q14568 | Y160 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | SAYLVAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERM |
| Q14568 | Y283 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | sDEEEEKKDGDKKKKKTKEKyIDQEELNKTKPIWTRNPDDI |
| Q14764 | Y389 | Sugiyama | MVP LRP | AKVEVVEERQAIPLDENEGIyVQDVKTGKVRAVIGSTYMLT |
| Q14974 | Y529 | Sugiyama | KPNB1 NTF97 | KLLETTDRPDGHQNNLRSSAyEsLMEIVKNSAKDCYPAVQK |
| Q14CX7 | Y19 | Sugiyama | NAA25 C12orf30 MDM20 NAP1 | __MATRGHVQDPNDRRLRPIyDyLDNGNNKMAIQQADKLLK |
| Q15024 | Y13 | Sugiyama | EXOSC7 KIAA0116 RRP42 | ________MASVTLSEAEKVyIVHGVQEDLRVDGRGCEDYR |
| Q15024 | Y187 | Sugiyama | EXOSC7 KIAA0116 RRP42 | RVRVLEDEEGsKDIELSDDPyDCIRLSVENVPCIVTLCKIG |
| Q15029 | Y161 | Sugiyama | EFTUD2 KIAA0031 SNRP116 | GKTCFVDCLIEQTHPEIRKRyDQDLCyTDILFTEQERGVGI |
| Q15056 | Y101 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | FKGFCyVEFDEVDsLKEALtyDGALLGDRsLRVDIAEGRKQ |
| Q15056 | Y86 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | sIRsVRLVRDKDTDKFKGFCyVEFDEVDsLKEALtyDGALL |
| Q15149 | Y3362 | Sugiyama | PLEC PLEC1 | TGLsLLPLSEKAARARQEELySELQAREtFEKTPVEVPVGG |
| Q15181 | Y169 | Sugiyama | PPA1 IOPPP PP | EGETDWKVIAINVDDPDAANyNDINDVKRLKPGYLEATVDW |
| Q15293 | T144 | Sugiyama | RCN1 RCN | WKDYDRDKDDKISWEEyKQAtyGyyLGNPAEFHDssDHHtF |
| Q15293 | Y145 | Sugiyama | RCN1 RCN | KDYDRDKDDKISWEEyKQAtyGyyLGNPAEFHDssDHHtFK |
| Q15293 | Y148 | Sugiyama | RCN1 RCN | DRDKDDKISWEEyKQAtyGyyLGNPAEFHDssDHHtFKKML |
| Q15293 | Y278 | Sugiyama | RCN1 RCN | LNKDGKLDKDEIRHWILPQDyDHAQAEARHLVyESDKNKDE |
| Q15369 | Y18 | Sugiyama | ELOC TCEB1 | ___MDGEEKtyGGCEGPDAMyVKLISSDGHEFIVKREHALt |
| Q15369 | Y8 | Sugiyama | ELOC TCEB1 | _____________MDGEEKtyGGCEGPDAMyVKLISSDGHE |
| Q15427 | Y16 | Sugiyama | SF3B4 SAP49 | _____MAAGPISERNQDAtVyVGGLDEKVSEPLLWELFLQA |
| Q15459 | S451 | Sugiyama | SF3A1 SAP114 | IGLLDPRWLEQRDRSIREKQsDDEVyAPGLDIESsLKQLAE |
| Q15459 | Y456 | Sugiyama | SF3A1 SAP114 | PRWLEQRDRSIREKQsDDEVyAPGLDIESsLKQLAERRtDI |
| Q15527 | Y123 | Sugiyama | SURF2 | GRRYQRALCKYEECQKQGVEyVPACLVHRRRRREDQMDGDG |
| Q15631 | Y210 | Sugiyama | TSN | sLRKRYDGLKYDVKKVEEVVyDLSIRGFNKETAAACVEK__ |
| Q15637 | Y87 | Sugiyama | SF1 ZFM1 ZNF162 | tGDLGIPPNPEDRsPsPEPIyNsEGKRLNTREFRTRKKLEE |
| Q15717 | Y109 | Sugiyama | ELAVL1 HUR | KTIKVSYARPssEVIKDANLyISGLPRTMtQKDVEDMFSRF |
| Q15785 | Y25 | Sugiyama | TOMM34 URCC3 | FPDsVEELRAAGNESFRNGQyAEASALyGRALRVLQAQGss |
| Q15785 | Y32 | Sugiyama | TOMM34 URCC3 | LRAAGNESFRNGQyAEASALyGRALRVLQAQGssDPEEEsV |
| Q15785 | Y54 | Sugiyama | TOMM34 URCC3 | RALRVLQAQGssDPEEEsVLysNRAACHLKDGNCRDCIKDC |
| Q16543 | Y248 | Sugiyama | CDC37 CDC37A | VDPRACFRQFFTKIKtADRQyMEGFNDELEAFKERVRGRAK |
| Q16595 | Y95 | Sugiyama | FXN FRDA X25 | LMNLRKsGtLGHPGsLDEttyERLAEETLDSLAEFFEDLAD |
| Q16719 | S443 | Sugiyama | KYNU | VVCDKRNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsAET |
| Q16719 | Y441 | Sugiyama | KYNU | RGVVCDKRNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsA |
| Q16719 | Y448 | Sugiyama | KYNU | RNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsAETKN___ |
| Q16719 | Y47 | Sugiyama | KYNU | ERVALHLDEEDKLRHFRECFyIPKIQDLPPVDLSLVNKDEN |
| Q16719 | Y86 | Sugiyama | KYNU | ENAIYFLGNSLGLQPKMVKtyLEEELDKWAKIAAYGHEVGK |
| Q16778 | Y38 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | AVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIssK |
| Q16778 | Y41 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | KAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIssKAMG |
| Q16778 | Y43 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | QKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIssKAMGIM |
| Q3V6T2 | Y1153 | Sugiyama | CCDC88A APE GRDN KIAA1212 | SSLENENESVIKEREDLKSLyDSLIKDHEKLELLHERQAsE |
| Q4VXU2 | Y291 | Sugiyama | PABPC1L C20orf119 | ERQNELKRRFEQMKQDRLRRyQGVNLyVKNLDDSIDDDKLR |
| Q4VXU2 | Y297 | Sugiyama | PABPC1L C20orf119 | KRRFEQMKQDRLRRyQGVNLyVKNLDDSIDDDKLRKEFSPY |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF3 | Y58 | Sugiyama | HSP90B2P GRP94B GRP94P1 TRAP1 | VTFKSILFVPTFVPRGLFDEyGsKKSDYIKLYVRCVFITDD |
| Q58FF6 | Y32 | Sugiyama | HSP90AB4P | KEIFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDII |
| Q58FF7 | Y492 | Sugiyama | HSP90AB3P HSP90BC | TANMEQIMKAQALRDNstMGyMMAKKHLEINPDHPIMETLR |
| Q58FF7 | Y56 | Sugiyama | HSP90AB3P HSP90BC | EEIFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FF8 | Y198 | Sugiyama | HSP90AB2P HSP90BB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKTKPIWTRNTEDI |
| Q58FF8 | Y260 | Sugiyama | HSP90AB2P HSP90BB | VRYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVW |
| Q58FF8 | Y261 | Sugiyama | HSP90AB2P HSP90BB | RYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVWK |
| Q58FF8 | Y56 | Sugiyama | HSP90AB2P HSP90BB | KEIFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FG0 | Y177 | Sugiyama | HSP90AA5P HSP90AE | GQLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQ |
| Q58FG0 | Y178 | Sugiyama | HSP90AA5P HSP90AE | QLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQK |
| Q5QNW6 | Y38 | Sugiyama | H2BC18 HIST2H2BF | AVTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q5QNW6 | Y41 | Sugiyama | H2BC18 HIST2H2BF | KVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q5QNW6 | Y43 | Sugiyama | H2BC18 HIST2H2BF | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q5VTE0 | Y29 | Sugiyama | EEF1A1P5 EEF1AL3 | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| Q5VV41 | Y216 | Sugiyama | ARHGEF16 EPHEXIN4 NBR | KKTLGRKRGHKGsFKDDPQLyQEIQERGLNtsQEsDDDILD |
| Q66LE6 | Y80 | Sugiyama | PPP2R2D KIAA1541 | IFQREQENKSRPHSRGEyNVystFQsHEPEFDyLKSLEIEE |
| Q6DN03 | Y38 | Sugiyama | H2BC20P HIST2H2BC | AVTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCK |
| Q6DN03 | Y41 | Sugiyama | H2BC20P HIST2H2BC | KAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKAMG |
| Q6DN03 | Y43 | Sugiyama | H2BC20P HIST2H2BC | QKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKAMGIM |
| Q6DRA6 | Y38 | Sugiyama | H2BC19P HIST2H2BD | AVTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCK |
| Q6DRA6 | Y41 | Sugiyama | H2BC19P HIST2H2BD | KAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKAMG |
| Q6DRA6 | Y43 | Sugiyama | H2BC19P HIST2H2BD | QKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKAMGIM |
| Q6PEY2 | Y224 | Sugiyama | TUBA3E | VDNEAIYDICRRNLDIERPtytNLNRLIGQIVSSITASLRF |
| Q6PKG0 | Y633 | Sugiyama | LARP1 KIAA0731 LARP | MEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVtQtPHyM |
| Q6S8J3 | Y1062 | Sugiyama | POTEE A26C1A POTE2 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q71U36 | Y103 | Sugiyama | TUBA1A TUBA3 | yRQLFHPEQLItGKEDAANNyARGHYTIGKEIIDLVLDRIR |
| Q71U36 | Y224 | Sugiyama | TUBA1A TUBA3 | VDNEAIYDICRRNLDIERPtytNLNRLIGQIVSSITASLRF |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q7KZF4 | Y476 | Sugiyama | SND1 TDRD11 | SKGLATVIRYRQDDDQRssHyDELLAAEARAIKNGKGLHSK |
| Q7RTV0 | Y100 | Sugiyama | PHF5A | KDRDGCPKIVNLGSsKTDLFyERKKYGFKKR__________ |
| Q7Z2W4 | Y642 | Sugiyama | ZC3HAV1 ZC3HDC2 PRO1677 | GEEKDKRKNsNVDssyLEsLyQSCPRGVVPFQAGSRNYELS |
| Q7Z417 | S652 | Sugiyama | NUFIP2 KIAA1321 PIG1 | NtLLGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsI |
| Q86U44 | Y518 | Sugiyama | METTL3 MTA70 | LDCDVIVAEVRSTSHKPDEIyGMIERLsPGTRKIELFGRPH |
| Q86V81 | Y250 | Sugiyama | ALYREF ALY BEF THOC4 | AGRNSKQQLsAEELDAQLDAyNARMDts_____________ |
| Q8IWW6 | T231 | Sugiyama | ARHGAP12 | QDSEsGDELSSSsTEQIRAttPPNQGRPDsPVyANLQELKI |
| Q8IWW6 | Y243 | Sugiyama | ARHGAP12 | sTEQIRAttPPNQGRPDsPVyANLQELKISQSALPPLPGSP |
| Q8IWX8 | Y714 | Sugiyama | CHERP DAN26 SCAF6 | YsPPSHDRPRNsEGWEQNGLyEFFRAKMRARRRKGQEKRNS |
| Q8IXH6 | Y211 | Sugiyama | TP53INP2 C20orf110 DOR PINH | RQNRARESRPRRSKNQSsFIyQPCQRQFNY___________ |
| Q8N0Y7 | S137 | Sugiyama | PGAM4 PGAM3 | RsyDVPPPPMEPDHPFysNIsKDRRYADLTEDQLPSYESPK |
| Q8N0Y7 | Y133 | Sugiyama | PGAM4 PGAM3 | KIWRRsyDVPPPPMEPDHPFysNIsKDRRYADLTEDQLPSY |
| Q8N0Y7 | Y92 | Sugiyama | PGAM4 PGAM3 | DAIDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQV |
| Q8N257 | Y38 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | AVTKAQKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIssK |
| Q8N257 | Y41 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | KAQKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIssKAMG |
| Q8N257 | Y43 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | QKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIssKAMGIM |
| Q8N5P1 | Y76 | Sugiyama | ZC3H8 ZC3HDC8 | SAISPKSSLHRKSRSKDYDVysDNDICsQEsEDNFAKELQQ |
| Q8NBS9 | Y251 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | ALGLEHSETVKIGKVDCtQHyELCsGNQVRGyPtLLWFRDG |
| Q8NBS9 | Y289 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | RDGKKVDQYKGKRDLEsLREyVEsQLQRTETGATETVTPSE |
| Q8NI22 | Y135 | Sugiyama | MCFD2 SDNSF | DELINIIDGVLRDDDKNNDGyIDyAEFAKSLQ_________ |
| Q8TDD1 | Y681 | Sugiyama | DDX54 | GPNRGAKRRREEARQRDQEFyIPyRPKDFDSERGLsIsGEG |
| Q8TEW0 | Y388 | Sugiyama | PARD3 PAR3 PAR3A | QLSQSEKNNyyssRFsPDsQyIDNRSVNSAGLHTVQRAPRL |
| Q8WVJ2 | Y145 | Sugiyama | NUDCD2 | ERFQKENPGFDFsGAEIsGNytKGGPDFsNLEK________ |
| Q8WWM7 | S276 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | MFKFNEENyGVKTtyDssLssytVPLEKDNsEEFRQRELRA |
| Q8WWM7 | Y270 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | GWDPNEMFKFNEENyGVKTtyDssLssytVPLEKDNsEEFR |
| Q8WYP5 | Y1790 | Sugiyama | AHCTF1 ELYS TMBS62 MSTP108 | QSVRKKTRKAKEISEASENIySDVRGLsQNQQIPQNsVtPR |
| Q92522 | Y48 | Sugiyama | H1-10 H1FX | AALsPsKKRKNSKKKNQPGKySQLVVEtIRRLGERNGSSLA |
| Q92598 | Y641 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | MIMQDKLEKERNDAKNAVEEyVyEFRDKLCGPYEKFICEQD |
| Q92598 | Y643 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | MQDKLEKERNDAKNAVEEyVyEFRDKLCGPYEKFICEQDHQ |
| Q92626 | Y916 | Sugiyama | PXDN KIAA0230 MG50 PRG2 PXD01 VPO VPO1 | SVYPREQINQLtsyIDASNVyGsTEHEARSIRDLASHRGLL |
| Q93079 | Y38 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q93079 | Y41 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q93079 | Y43 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q969T4 | Y91 | Sugiyama | UBE2E3 UBCE4 UBCH9 | AEITLDPPPNCSAGPKGDNIyEWRSTILGPPGSVYEGGVFF |
| Q96AY3 | Y201 | Sugiyama | FKBP10 FKBP65 PSEC0056 | YNGTLLDGTSFDTSYSKGGtyDtyVGsGWLIKGMDQGLLGM |
| Q96AY3 | Y204 | Sugiyama | FKBP10 FKBP65 PSEC0056 | TLLDGTSFDTSYSKGGtyDtyVGsGWLIKGMDQGLLGMCPG |
| Q96C19 | T84 | Sugiyama | EFHD2 SWS1 | DLNQGIGEPQsPsRRVFNPytEFKEFSRKQIKDMEKMFKQy |
| Q96D46 | Y459 | Sugiyama | NMD3 CGI-07 | YQDFLEDLEEDEAIRKNVNIyRDsAIPVEsDtDDEGAPRIS |
| Q96EU6 | Y138 | Sugiyama | RRP36 C6orf153 HSPC253 | RDPRFDDLSGEYNPEVFDKtyQFLNDIRAKEKELVKKQLKK |
| Q96GX9 | Y57 | Sugiyama | APIP CGI-29 | HLGWVTGTGGGISLKHGDEIyIAPsGVQKERIQPEDMFVCD |
| Q96HN2 | Y372 | Sugiyama | AHCYL2 KIAA0828 | LCVPAMNVNDSVTKQKFDNLyCCRESILDGLKRTTDMMFGG |
| Q96IR7 | Y67 | Sugiyama | HPDL GLOXD1 | LRSGDAVFLVNEGAGSGEPLyGLDPRHAVPSATNLCFDVAD |
| Q96LR5 | Y85 | Sugiyama | UBE2E2 UBCH8 | AEITLDPPPNCSAGPKGDNIyEWRSTILGPPGSVYEGGVFF |
| Q96P70 | Y889 | Sugiyama | IPO9 IMP9 KIAA1192 RANBP9 HSPC273 | HGINADDKRLQDIRVKGEEIysMDEGIRTRSKSAKNPERWT |
| Q96QK1 | S500 | Sugiyama | VPS35 MEM3 TCCCTA00141 | DPEDFADEQSLVGRFIHLLRsEDPDQQyLILNTARKHFGAG |
| Q96RT6 | Y307 | Sugiyama | CTAGE1 CTAGE2 | IHAAKLNASLKTLEGERNQIyIQLSEVDKTKEELTEHIKNL |
| Q99460 | Y494 | Sugiyama | PSMD1 | RHGGSLGLGLAAMGTARQDVyDLLKTNLYQDDAVTGEAAGL |
| Q99536 | Y240 | Sugiyama | VAT1 | TASASKHEALKENGVTHPIDyHttDyVDEIKKISPKGVDIV |
| Q99536 | Y245 | Sugiyama | VAT1 | KHEALKENGVTHPIDyHttDyVDEIKKISPKGVDIVMDPLG |
| Q99543 | S275 | Sugiyama | DNAJC2 MPHOSPH11 MPP11 ZRF1 | RAQRKKEEMNRIRtLVDNAysCDPRIKKFKEEEKAKKEAEK |
| Q99543 | Y274 | Sugiyama | DNAJC2 MPHOSPH11 MPP11 ZRF1 | TRAQRKKEEMNRIRtLVDNAysCDPRIKKFKEEEKAKKEAE |
| Q99543 | Y90 | Sugiyama | DNAJC2 MPHOSPH11 MPP11 ZRF1 | LEEFPMLKTLDPKDWKNQDHyAVLGLGHVRYKATQRQIKAA |
| Q99613 | Y881 | Sugiyama | EIF3C EIF3S8 | EKLGsLVENNERVFDHKQGtyGGyFRDQKDGYRKNEGYMRR |
| Q99613 | Y884 | Sugiyama | EIF3C EIF3S8 | GsLVENNERVFDHKQGtyGGyFRDQKDGYRKNEGYMRRGGY |
| Q99733 | Y55 | Sugiyama | NAP1L4 NAP2 | PRVLAALQERLDNVPHtPssyIEtLPKAVKRRINALKQLQV |
| Q99733 | Y95 | Sugiyama | NAP1L4 NAP2 | VRCAHIEAKFyEEVHDLERKyAALyQPLFDKRREFItGDVE |
| Q99733 | Y99 | Sugiyama | NAP1L4 NAP2 | HIEAKFyEEVHDLERKyAALyQPLFDKRREFItGDVEPtDA |
| Q99798 | Y71 | Sugiyama | ACO2 | NINIVRKRLNRPLTLSEKIVyGHLDDPAsQEIERGKSYLRL |
| Q99848 | Y265 | Sugiyama | EBNA1BP2 EBP2 | NQKFGFGGKKKGSKWNtREsyDDVssFRAKTAHGRGLKRPG |
| Q99877 | Y38 | Sugiyama | H2BC15 H2BFD HIST1H2BN | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q99877 | Y41 | Sugiyama | H2BC15 H2BFD HIST1H2BN | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99877 | Y43 | Sugiyama | H2BC15 H2BFD HIST1H2BN | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q99879 | Y38 | Sugiyama | H2BC14 H2BFE HIST1H2BM | AINKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q99879 | Y41 | Sugiyama | H2BC14 H2BFE HIST1H2BM | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99879 | Y43 | Sugiyama | H2BC14 H2BFE HIST1H2BM | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q99880 | Y38 | Sugiyama | H2BC13 H2BFC HIST1H2BL | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q99880 | Y41 | Sugiyama | H2BC13 H2BFC HIST1H2BL | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99880 | Y43 | Sugiyama | H2BC13 H2BFC HIST1H2BL | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q9BPX3 | Y929 | Sugiyama | NCAPG CAPG NYMEL3 | QDATLTTTTFQNEDEKNKEVyMtPLRGVKATQASKSTQLKT |
| Q9BQE3 | Y103 | Sugiyama | TUBA1C TUBA6 | yRQLFHPEQLItGKEDAANNyARGHYTIGKEIIDLVLDRIR |
| Q9BQE3 | Y224 | Sugiyama | TUBA1C TUBA6 | VDNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLRF |
| Q9BQE3 | Y432 | Sugiyama | TUBA1C TUBA6 | GMEEGEFSEAREDMAALEKDyEEVGADsADGEDEGEEy___ |
| Q9BRL6 | Y44 | Sugiyama | SRSF8 SFRS2B SRP46 | RtsPDsLRRVFEKYGRVGDVyIPREPHTKAPRGFAFVRFHD |
| Q9BS40 | Y20 | Sugiyama | LXN | _MEIPPTNYPASRAALVAQNyINyQQGTPHRVFEVQKVKQA |
| Q9BS40 | Y23 | Sugiyama | LXN | IPPTNYPASRAALVAQNyINyQQGTPHRVFEVQKVKQAsME |
| Q9BT78 | Y167 | Sugiyama | COPS4 CSN4 | TYLKIARLYLEDDDPVQAEAyINRASLLQNESTNEQLQIHY |
| Q9BUJ2 | Y510 | Sugiyama | HNRNPUL1 E1BAP5 HNRPUL1 | RLIQIAARKKRNyILDQtNVyGsAQRRKMRPFEGFQRKAIV |
| Q9BVA1 | T107 | Sugiyama | TUBB2B | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESESC |
| Q9BVA1 | Y106 | Sugiyama | TUBB2B | RPDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESES |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9BYX7 | Y362 | Sugiyama | POTEKP ACTBL3 FKSG30 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q9H3G5 | Y199 | Sugiyama | CPVL VLP PSEC0124 UNQ197/PRO223 | LYSALIQFFQIFPEYKNNDFyVTGESyAGKYVPAIAHLIHS |
| Q9H4M9 | Y339 | Sugiyama | EHD1 PAST PAST1 CDABP0131 | PNVFGKESKKKELVNNLGEIyQKIEREHQIsPGDFPsLRKM |
| Q9H7Z7 | Y308 | Sugiyama | PTGES2 C9orf15 PGES2 | LISKRLKSRHRLQDNVREDLyEAADKWVAAVGKDRPFMGGQ |
| Q9HAP6 | Y118 | Sugiyama | LIN7B MALS2 VELI2 UNQ3116/PRO10200 | KTDEGLGFNIMGGKEQNsPIyIsRVIPGGVADRHGGLKRGD |
| Q9NQR4 | Y202 | Sugiyama | NIT2 CUA002 | TTGPAHWELLQRSRAVDNQVyVAtAsPARDDKASYVAWGHS |
| Q9NR46 | Y77 | Sugiyama | SH3GLB2 KIAA1848 PP578 | LRQTEVLLQPNPSARVEEFLyEKLDRKVPSRVTNGELLAQY |
| Q9NRH3 | Y60 | Sugiyama | TUBG2 | FATEGTDRKDVFFyQADDEHyIPRAVLLDLEPRVIHSILNs |
| Q9NRX4 | Y57 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | AAESKEIVRGYKWAEyHADIyDKVSGDMQKQGCDCECLGGG |
| Q9NUP9 | Y118 | Sugiyama | LIN7C MALS3 VELI3 | KTEEGLGFNIMGGKEQNsPIyIsRIIPGGIADRHGGLKRGD |
| Q9NVS9 | Y256 | Sugiyama | PNPO | LPtGDsPLGPMTHRGEEDWLyERLAP_______________ |
| Q9NWS0 | Y194 | Sugiyama | PIH1D1 NOP17 | IsQQNIRSEQRPRIQELGDLytPAPGRAESGPEKPHLNLWL |
| Q9NX18 | Y105 | Sugiyama | SDHAF2 C11orf79 PGL2 SDH5 | LLSLFAKEHLQHMTEKQLNLyDRLINEPSNDWDIYYWATEA |
| Q9NXV6 | T114 | Sugiyama | CDKN2AIP CARF | QKVMDKILSMAEGIKVtDAPtyTTRDELVAKVKKRGIsssN |
| Q9NXV6 | Y115 | Sugiyama | CDKN2AIP CARF | KVMDKILSMAEGIKVtDAPtyTTRDELVAKVKKRGIsssNE |
| Q9NXZ1 | Y528 | Sugiyama | SAGE1 SAGE | APQLGHMAAGGIPSMSTKDLyATVTQNVHEERMENNQPQPS |
| Q9NY65 | Y103 | Sugiyama | TUBA8 TUBAL2 | YRQLFHPEQLItGKEDAANNyARGHYTVGKESIDLVLDRIR |
| Q9NY65 | Y224 | Sugiyama | TUBA8 TUBAL2 | VDNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLRF |
| Q9NYU2 | Y779 | Sugiyama | UGGT1 GT UGCGL1 UGGT UGT1 UGTR | RPVTFWIVGDFDSPSGRQLLyDAIKHQKSSNNVRISMINNP |
| Q9UBQ7 | Y255 | Sugiyama | GRHPR GLXR MSTP035 | KETAVFINISRGDVVNQDDLyQALAsGKIAAAGLDVtsPEP |
| Q9UBR2 | Y76 | Sugiyama | CTSZ | YLSPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHA |
| Q9UDY2 | Y506 | Sugiyama | TJP2 X104 ZO2 | PQPKAAPRtFLRPsPEDEAIyGPNTKMVRFKKGDSVGLRLA |
| Q9UDY4 | Y172 | Sugiyama | DNAJB4 DNAJW HLJ1 | SRLKQDPPVIHELRVsLEEIySGCTKRMKISRKRLNADGRS |
| Q9UFW8 | Y20 | Sugiyama | CGGBP1 CGGBP | _MERFVVTAPPARNRSKTALyVtPLDRVTEFGGELHEDGGK |
| Q9UHX1 | Y229 | Sugiyama | PUF60 FIR ROBPI SIAHBP1 | GQAQPIIDQLAEEARAFNRIyVAsVHQDLsDDDIKSVFEAF |
| Q9UI15 | Y192 | Sugiyama | TAGLN3 NP25 | NVIGLQMGSNKGAsQAGMtGyGMPRQIM_____________ |
| Q9UKK9 | Y16 | Sugiyama | NUDT5 NUDIX5 HSPC115 | _____MEsQEPtEssQNGKQyIISEELIsEGKWVKLEKTTY |
| Q9UKS6 | Y206 | Sugiyama | PACSIN3 | RKLQERVERCAKEAEKTKAQyEQtLAELHRYTPRYMEDMEQ |
| Q9UKV3 | Y1086 | Sugiyama | ACIN1 ACINUS KIAA0670 | RTALHGVKWPQSNPKFLCADyAEQDELDyHRGLLVDRPsEt |
| Q9UNF0 | Y267 | Sugiyama | PACSIN2 | VLLEVQKHLDLSNVAGYKAIyHDLEQsIRAADAVEDLRWFR |
| Q9UQ80 | Y343 | Sugiyama | PA2G4 EBP1 | VLLMPNGPMRITsGPFEPDLyKsEMEVQDAELKALLQssAs |
| Q9Y262 | Y409 | Sugiyama | EIF3L EIF3EIP EIF3S6IP HSPC021 HSPC025 MSTP005 | QLREKYGDKMLRMQKGDPQVyEELFsysCPKFLSPVVPNYD |
| Q9Y265 | Y192 | Sugiyama | RUVBL1 INO80H NMP238 TIP49 TIP49A | LDPSIFEsLQKERVEAGDVIyIEANSGAVKRQGRCDTYAtE |
| Q9Y265 | Y438 | Sugiyama | RUVBL1 INO80H NMP238 TIP49 TIP49A | KINGKDSIEKEHVEEIsELFyDAKSSAKILADQQDKYMK__ |
| Q9Y281 | Y82 | Sugiyama | CFL2 | DTVEDPYtsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFI |
| Q9Y281 | Y85 | Sugiyama | CFL2 | EDPYtsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWA |
| Q9Y281 | Y89 | Sugiyama | CFL2 | tsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWAPESA |
| Q9Y2W1 | T230 | Sugiyama | THRAP3 BCLAF2 TRAP150 | tsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERsPA |
| Q9Y2W1 | Y228 | Sugiyama | THRAP3 BCLAF2 TRAP150 | GGtsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERs |
| Q9Y2W2 | Y236 | Sugiyama | WBP11 NPWBP SIPP1 SNP70 | GRKVGFALDLPPRRRDEDMLysPELAQRGHDDDVSSTSEDD |
| Q9Y3D8 | Y31 | Sugiyama | AK6 CINAP AD-004 CGI-137 | TPGVGKTTLGKELASKSGLKyINVGDLAREEQLYDGYDEEY |
| Q9Y3F4 | Y280 | Sugiyama | STRAP MAWD UNRIP | syKGHFGPIHCVRFSPDGELyAsGSEDGTLRLWQTVVGKty |
| Q9Y3F4 | Y300 | Sugiyama | STRAP MAWD UNRIP | yAsGSEDGTLRLWQTVVGKtyGLWKCVLPEEDsGELAKPKI |
| Q9Y3P9 | Y472 | Sugiyama | RABGAP1 HSPC094 | FFLKLKQIKQRERKNNTDTLyEVVCLESESERERRKTTAsP |
| Q9Y3U8 | Y53 | Sugiyama | RPL36 | LTKHTKFVRDMIREVCGFAPyERRAMELLKVSKDKRALKFI |
| Q9Y4L1 | Y116 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | TLRYFQHLLGKQADNPHVALyQARFPEHELTFDPQRQTVHF |
| Q9Y5S9 | Y54 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KRKGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWI |
| Q9Y639 | Y216 | Sugiyama | NPTN SDFR1 SDR1 | KNASNMEYRINKPRAEDsGEyHCVyHFVsAPKANATIEVKA |
| Q9Y639 | Y220 | Sugiyama | NPTN SDFR1 SDR1 | NMEYRINKPRAEDsGEyHCVyHFVsAPKANATIEVKAAPDI |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.497513e-13 | 12.347 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.296718e-12 | 11.639 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 7.487354e-09 | 8.126 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.379234e-08 | 7.624 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.523874e-08 | 7.344 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 2.661544e-07 | 6.575 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.094379e-06 | 5.961 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.285256e-06 | 5.891 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.522784e-06 | 5.817 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 3.857365e-06 | 5.414 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 5.263824e-06 | 5.279 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.053478e-05 | 4.515 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.301209e-05 | 4.366 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.302422e-05 | 4.366 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 7.430260e-05 | 4.129 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 7.886631e-05 | 4.103 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 7.571324e-05 | 4.121 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 8.308914e-05 | 4.080 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.181343e-04 | 3.928 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.545683e-04 | 3.811 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.546502e-04 | 3.811 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.691042e-04 | 3.772 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.795763e-04 | 3.746 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.795763e-04 | 3.746 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.128353e-04 | 3.672 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.343718e-04 | 3.476 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 3.692264e-04 | 3.433 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.072497e-04 | 3.390 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 4.167588e-04 | 3.380 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 4.762584e-04 | 3.322 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 5.816237e-04 | 3.235 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 6.929069e-04 | 3.159 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 6.929069e-04 | 3.159 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 7.713012e-04 | 3.113 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 8.908529e-04 | 3.050 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.129105e-03 | 2.947 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 1.417722e-03 | 2.848 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.516534e-03 | 2.819 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.536252e-03 | 2.814 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 1.763037e-03 | 2.754 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 1.728025e-03 | 2.762 | 1 | 1 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 2.185132e-03 | 2.661 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.836013e-03 | 2.547 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.245116e-03 | 2.489 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 3.576566e-03 | 2.447 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.668697e-03 | 2.435 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 3.821355e-03 | 2.418 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 4.229142e-03 | 2.374 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 4.375505e-03 | 2.359 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 5.260980e-03 | 2.279 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 4.996535e-03 | 2.301 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 5.260980e-03 | 2.279 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.376191e-03 | 2.270 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 6.514939e-03 | 2.186 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 6.216136e-03 | 2.206 | 1 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 6.234900e-03 | 2.205 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 6.213738e-03 | 2.207 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 6.936261e-03 | 2.159 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 7.255720e-03 | 2.139 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.255720e-03 | 2.139 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 7.255720e-03 | 2.139 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 7.668462e-03 | 2.115 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 9.641160e-03 | 2.016 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 9.538879e-03 | 2.021 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 9.538879e-03 | 2.021 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 8.723441e-03 | 2.059 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 9.141592e-03 | 2.039 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 9.859423e-03 | 2.006 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.078496e-02 | 1.967 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.078496e-02 | 1.967 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.098311e-02 | 1.959 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.107758e-02 | 1.956 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.107758e-02 | 1.956 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.171779e-02 | 1.931 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.175862e-02 | 1.930 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.189703e-02 | 1.925 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.209880e-02 | 1.917 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.347899e-02 | 1.870 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 1.448871e-02 | 1.839 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.492415e-02 | 1.826 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.492415e-02 | 1.826 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.492415e-02 | 1.826 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.492415e-02 | 1.826 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.600142e-02 | 1.796 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 1.918996e-02 | 1.717 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 1.918996e-02 | 1.717 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.963590e-02 | 1.707 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.963590e-02 | 1.707 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 1.899064e-02 | 1.721 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 1.899064e-02 | 1.721 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 1.899064e-02 | 1.721 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 1.800394e-02 | 1.745 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 1.928386e-02 | 1.715 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.132750e-02 | 1.671 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.132750e-02 | 1.671 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.197174e-02 | 1.658 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.307743e-02 | 1.637 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.488445e-02 | 1.604 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.488445e-02 | 1.604 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 2.585765e-02 | 1.587 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.725493e-02 | 1.565 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.866474e-02 | 1.543 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 2.899826e-02 | 1.538 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.792990e-02 | 1.554 | 0 | 0 |
| Inhibition of membrane repair | R-HSA-9635644 | 2.864727e-02 | 1.543 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.163647e-02 | 1.500 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 3.008806e-02 | 1.522 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 2.811343e-02 | 1.551 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 2.811343e-02 | 1.551 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.866474e-02 | 1.543 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 2.674729e-02 | 1.573 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 3.162826e-02 | 1.500 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.671654e-02 | 1.573 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.265860e-02 | 1.486 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.265860e-02 | 1.486 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 3.348564e-02 | 1.475 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.685655e-02 | 1.433 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.801398e-02 | 1.420 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 3.902918e-02 | 1.409 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.902918e-02 | 1.409 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 4.511986e-02 | 1.346 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 4.582823e-02 | 1.339 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.582823e-02 | 1.339 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.729093e-02 | 1.325 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 4.729093e-02 | 1.325 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 4.756248e-02 | 1.323 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 4.756248e-02 | 1.323 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.818467e-02 | 1.317 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 4.818467e-02 | 1.317 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 5.022749e-02 | 1.299 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 5.058438e-02 | 1.296 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 5.302632e-02 | 1.276 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 5.647899e-02 | 1.248 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 5.647899e-02 | 1.248 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 5.550946e-02 | 1.256 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.059531e-02 | 1.218 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 6.557900e-02 | 1.183 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 6.557900e-02 | 1.183 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 6.860889e-02 | 1.164 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 5.789024e-02 | 1.237 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 5.803278e-02 | 1.236 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 7.121803e-02 | 1.147 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 6.895697e-02 | 1.161 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 7.110857e-02 | 1.148 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 7.396215e-02 | 1.131 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 7.459180e-02 | 1.127 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 7.459180e-02 | 1.127 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.472637e-02 | 1.127 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 7.955013e-02 | 1.099 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.027978e-02 | 1.095 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 8.239222e-02 | 1.084 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 8.351822e-02 | 1.078 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 8.351822e-02 | 1.078 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 8.351822e-02 | 1.078 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 8.653718e-02 | 1.063 | 0 | 0 |
| Immune System | R-HSA-168256 | 8.922982e-02 | 1.049 | 1 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 9.110055e-02 | 1.040 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 9.235909e-02 | 1.035 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 9.235909e-02 | 1.035 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 9.406122e-02 | 1.027 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.406122e-02 | 1.027 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.457870e-02 | 1.024 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 1.011152e-01 | 0.995 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.268832e-01 | 0.897 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.268832e-01 | 0.897 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.268832e-01 | 0.897 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.353083e-01 | 0.869 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.353083e-01 | 0.869 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 1.436527e-01 | 0.843 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.436527e-01 | 0.843 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.436527e-01 | 0.843 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.436527e-01 | 0.843 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.436527e-01 | 0.843 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.436527e-01 | 0.843 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.436527e-01 | 0.843 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.353083e-01 | 0.869 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.268832e-01 | 0.897 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.353083e-01 | 0.869 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.436527e-01 | 0.843 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.097874e-01 | 0.959 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 1.268832e-01 | 0.897 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.268832e-01 | 0.897 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.031056e-01 | 0.987 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.011152e-01 | 0.995 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 1.097874e-01 | 0.959 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.353083e-01 | 0.869 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.436527e-01 | 0.843 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.436527e-01 | 0.843 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.186741e-01 | 0.926 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.594744e-02 | 1.018 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.155144e-01 | 0.937 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 1.077637e-01 | 0.968 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 1.092626e-01 | 0.962 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.923724e-02 | 1.003 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.436527e-01 | 0.843 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 1.315213e-01 | 0.881 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.268832e-01 | 0.897 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 1.061718e-01 | 0.974 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.329620e-01 | 0.876 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.601021e-01 | 0.796 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.682087e-01 | 0.774 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 1.682087e-01 | 0.774 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.682087e-01 | 0.774 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.762376e-01 | 0.754 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.762376e-01 | 0.754 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.762376e-01 | 0.754 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 2.075903e-01 | 0.683 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.075903e-01 | 0.683 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 2.075903e-01 | 0.683 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 2.152414e-01 | 0.667 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.228191e-01 | 0.652 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 2.228191e-01 | 0.652 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 2.303241e-01 | 0.638 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 2.377570e-01 | 0.624 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 2.524097e-01 | 0.598 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 2.596307e-01 | 0.586 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 2.741634e-01 | 0.562 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.841895e-01 | 0.735 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 2.228191e-01 | 0.652 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 1.479987e-01 | 0.830 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.519170e-01 | 0.818 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 1.920650e-01 | 0.717 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 2.377570e-01 | 0.624 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.751452e-01 | 0.757 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 2.303241e-01 | 0.638 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.841895e-01 | 0.735 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.377570e-01 | 0.624 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 2.667824e-01 | 0.574 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.524097e-01 | 0.598 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.152414e-01 | 0.667 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 2.524097e-01 | 0.598 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.998651e-01 | 0.699 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.841895e-01 | 0.735 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.524097e-01 | 0.598 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.596307e-01 | 0.586 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 2.878283e-01 | 0.541 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.519170e-01 | 0.818 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 1.601021e-01 | 0.796 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 1.841895e-01 | 0.735 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 2.738655e-01 | 0.562 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.738655e-01 | 0.562 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 2.878283e-01 | 0.541 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 2.878283e-01 | 0.541 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 2.377570e-01 | 0.624 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.820534e-01 | 0.740 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 1.762376e-01 | 0.754 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 2.878283e-01 | 0.541 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 2.152414e-01 | 0.667 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.667824e-01 | 0.574 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 2.800289e-01 | 0.553 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.601021e-01 | 0.796 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.601021e-01 | 0.796 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.998651e-01 | 0.699 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.998651e-01 | 0.699 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 2.377570e-01 | 0.624 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.682087e-01 | 0.774 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.488208e-01 | 0.604 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 2.852706e-01 | 0.545 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 2.852706e-01 | 0.545 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 1.890017e-01 | 0.724 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.920650e-01 | 0.717 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.920650e-01 | 0.717 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 1.920650e-01 | 0.717 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 2.738655e-01 | 0.562 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.606874e-01 | 0.794 | 1 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.513435e-01 | 0.820 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.667824e-01 | 0.574 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 2.738655e-01 | 0.562 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 2.808806e-01 | 0.551 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 2.393446e-01 | 0.621 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.228191e-01 | 0.652 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.228191e-01 | 0.652 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 2.667824e-01 | 0.574 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.277591e-01 | 0.643 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.795089e-01 | 0.554 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.348750e-01 | 0.629 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 1.762376e-01 | 0.754 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.228191e-01 | 0.652 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 2.878283e-01 | 0.541 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.420039e-01 | 0.616 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 2.377570e-01 | 0.624 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.519170e-01 | 0.818 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.920650e-01 | 0.717 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.852706e-01 | 0.545 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.228191e-01 | 0.652 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.524097e-01 | 0.598 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.334270e-01 | 0.632 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.998651e-01 | 0.699 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.451187e-01 | 0.611 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 1.446695e-01 | 0.840 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.377570e-01 | 0.624 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 2.667824e-01 | 0.574 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 2.667824e-01 | 0.574 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.547034e-01 | 0.811 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 2.738655e-01 | 0.562 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.580776e-01 | 0.801 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 2.738655e-01 | 0.562 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 1.547034e-01 | 0.811 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 2.598626e-01 | 0.585 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 2.232656e-01 | 0.651 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.527147e-01 | 0.597 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.947094e-01 | 0.531 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.947094e-01 | 0.531 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 2.947094e-01 | 0.531 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 2.947094e-01 | 0.531 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 2.947094e-01 | 0.531 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.947094e-01 | 0.531 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.015243e-01 | 0.521 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 3.015243e-01 | 0.521 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 3.015243e-01 | 0.521 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 3.015243e-01 | 0.521 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.062704e-01 | 0.514 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.082739e-01 | 0.511 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.149586e-01 | 0.502 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.149586e-01 | 0.502 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.149586e-01 | 0.502 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 3.149586e-01 | 0.502 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 3.177420e-01 | 0.498 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.215792e-01 | 0.493 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 3.240046e-01 | 0.489 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.240046e-01 | 0.489 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.281362e-01 | 0.484 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 3.281362e-01 | 0.484 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 3.281362e-01 | 0.484 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 3.281362e-01 | 0.484 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 3.346302e-01 | 0.475 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 3.346302e-01 | 0.475 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.346302e-01 | 0.475 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 3.346302e-01 | 0.475 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 3.346302e-01 | 0.475 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 3.346302e-01 | 0.475 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 3.373189e-01 | 0.472 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.381107e-01 | 0.471 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.381107e-01 | 0.471 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 3.410618e-01 | 0.467 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.410618e-01 | 0.467 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.410618e-01 | 0.467 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 3.410618e-01 | 0.467 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 3.410618e-01 | 0.467 | 0 | 0 |
| Disease | R-HSA-1643685 | 3.419451e-01 | 0.466 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 3.451314e-01 | 0.462 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 3.474316e-01 | 0.459 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 3.512860e-01 | 0.454 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.590997e-01 | 0.445 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.590997e-01 | 0.445 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.599884e-01 | 0.444 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.599884e-01 | 0.444 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 3.599884e-01 | 0.444 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 3.661764e-01 | 0.436 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 3.661764e-01 | 0.436 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 3.661764e-01 | 0.436 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.666269e-01 | 0.436 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.723050e-01 | 0.429 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 3.723050e-01 | 0.429 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.723050e-01 | 0.429 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 3.723050e-01 | 0.429 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 3.723050e-01 | 0.429 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 3.723050e-01 | 0.429 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 3.843861e-01 | 0.415 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 3.843861e-01 | 0.415 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 3.843861e-01 | 0.415 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 3.903398e-01 | 0.409 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 3.903398e-01 | 0.409 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 3.903398e-01 | 0.409 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.904789e-01 | 0.408 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 3.962362e-01 | 0.402 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 3.962362e-01 | 0.402 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 3.969183e-01 | 0.401 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.020759e-01 | 0.396 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 4.020759e-01 | 0.396 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 4.060617e-01 | 0.391 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.078596e-01 | 0.389 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.078596e-01 | 0.389 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 4.078596e-01 | 0.389 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.078596e-01 | 0.389 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.135876e-01 | 0.383 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 4.135876e-01 | 0.383 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 4.192606e-01 | 0.378 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 4.248790e-01 | 0.372 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.248790e-01 | 0.372 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.248790e-01 | 0.372 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 4.248790e-01 | 0.372 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.266560e-01 | 0.370 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 4.304435e-01 | 0.366 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 4.402514e-01 | 0.356 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.414124e-01 | 0.355 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.414124e-01 | 0.355 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.414124e-01 | 0.355 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.467694e-01 | 0.350 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.468178e-01 | 0.350 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.468178e-01 | 0.350 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.468178e-01 | 0.350 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.468178e-01 | 0.350 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.468178e-01 | 0.350 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 4.468178e-01 | 0.350 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.521713e-01 | 0.345 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.521713e-01 | 0.345 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.532452e-01 | 0.344 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.545594e-01 | 0.342 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 4.574733e-01 | 0.340 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.574733e-01 | 0.340 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 4.574733e-01 | 0.340 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 4.627244e-01 | 0.335 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.627244e-01 | 0.335 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.627244e-01 | 0.335 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.627244e-01 | 0.335 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.627244e-01 | 0.335 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.628781e-01 | 0.335 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 4.660672e-01 | 0.332 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 4.679249e-01 | 0.330 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 4.730754e-01 | 0.325 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 4.730754e-01 | 0.325 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.766340e-01 | 0.322 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 4.781764e-01 | 0.320 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 4.781764e-01 | 0.320 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 4.787116e-01 | 0.320 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 4.832283e-01 | 0.316 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 4.832283e-01 | 0.316 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 4.832283e-01 | 0.316 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 4.832283e-01 | 0.316 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 4.832283e-01 | 0.316 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 4.832283e-01 | 0.316 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 4.880753e-01 | 0.312 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 4.882316e-01 | 0.311 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 4.882316e-01 | 0.311 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 4.892396e-01 | 0.310 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 4.911733e-01 | 0.309 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 4.911733e-01 | 0.309 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 4.931868e-01 | 0.307 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 4.931868e-01 | 0.307 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 4.931868e-01 | 0.307 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 4.980943e-01 | 0.303 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 4.980943e-01 | 0.303 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.989547e-01 | 0.302 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 5.034479e-01 | 0.298 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 5.072434e-01 | 0.295 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.172566e-01 | 0.286 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 5.172566e-01 | 0.286 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 5.311496e-01 | 0.275 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.356918e-01 | 0.271 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.356918e-01 | 0.271 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 5.356918e-01 | 0.271 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 5.356918e-01 | 0.271 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 5.401902e-01 | 0.267 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.446453e-01 | 0.264 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 5.446453e-01 | 0.264 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.490576e-01 | 0.260 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 5.490576e-01 | 0.260 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 5.518295e-01 | 0.258 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 5.534273e-01 | 0.257 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 5.534273e-01 | 0.257 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 5.562774e-01 | 0.255 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 5.562774e-01 | 0.255 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.577550e-01 | 0.254 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.577550e-01 | 0.254 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.662857e-01 | 0.247 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 5.662857e-01 | 0.247 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 5.704896e-01 | 0.244 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 5.746530e-01 | 0.241 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 5.746530e-01 | 0.241 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 5.746530e-01 | 0.241 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 5.757281e-01 | 0.240 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 5.787762e-01 | 0.237 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.828598e-01 | 0.234 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 5.828598e-01 | 0.234 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 5.838733e-01 | 0.234 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 5.909092e-01 | 0.228 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 5.948759e-01 | 0.226 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 5.969880e-01 | 0.224 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 5.988043e-01 | 0.223 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 5.988106e-01 | 0.223 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.050321e-01 | 0.218 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 6.065480e-01 | 0.217 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 6.065480e-01 | 0.217 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.103640e-01 | 0.214 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.103640e-01 | 0.214 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 6.141432e-01 | 0.212 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 6.178409e-01 | 0.209 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 6.178860e-01 | 0.209 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 6.206272e-01 | 0.207 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.215927e-01 | 0.206 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.215927e-01 | 0.206 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 6.220783e-01 | 0.206 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 6.252637e-01 | 0.204 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 6.278584e-01 | 0.202 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 6.288992e-01 | 0.201 | 0 | 0 |
| Protein folding | R-HSA-391251 | 6.288992e-01 | 0.201 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 6.324998e-01 | 0.199 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 6.324998e-01 | 0.199 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 6.352380e-01 | 0.197 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 6.352380e-01 | 0.197 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.395971e-01 | 0.194 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 6.395971e-01 | 0.194 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 6.430945e-01 | 0.192 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.430945e-01 | 0.192 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.465581e-01 | 0.189 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 6.465581e-01 | 0.189 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 6.479784e-01 | 0.188 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 6.499884e-01 | 0.187 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 6.533856e-01 | 0.185 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 6.533856e-01 | 0.185 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 6.533856e-01 | 0.185 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 6.567500e-01 | 0.183 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 6.567500e-01 | 0.183 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 6.590155e-01 | 0.181 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 6.592142e-01 | 0.181 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 6.600820e-01 | 0.180 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 6.633818e-01 | 0.178 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 6.666499e-01 | 0.176 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 6.666499e-01 | 0.176 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 6.698863e-01 | 0.174 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 6.726814e-01 | 0.172 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 6.730916e-01 | 0.172 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 6.730916e-01 | 0.172 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 6.730916e-01 | 0.172 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 6.762659e-01 | 0.170 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 6.762659e-01 | 0.170 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 6.793475e-01 | 0.168 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 6.794096e-01 | 0.168 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 6.825230e-01 | 0.166 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 6.856064e-01 | 0.164 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 6.856064e-01 | 0.164 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 6.886599e-01 | 0.162 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.886599e-01 | 0.162 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 6.916840e-01 | 0.160 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.916840e-01 | 0.160 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 6.944745e-01 | 0.158 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 6.946790e-01 | 0.158 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 6.946790e-01 | 0.158 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 6.957111e-01 | 0.158 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 6.965871e-01 | 0.157 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 6.973675e-01 | 0.157 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.005824e-01 | 0.155 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.034914e-01 | 0.153 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.034914e-01 | 0.153 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 7.063723e-01 | 0.151 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 7.069707e-01 | 0.151 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 7.092254e-01 | 0.149 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 7.110411e-01 | 0.148 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.120510e-01 | 0.147 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 7.148127e-01 | 0.146 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 7.148493e-01 | 0.146 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 7.148493e-01 | 0.146 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 7.197807e-01 | 0.143 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 7.230831e-01 | 0.141 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.257749e-01 | 0.139 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.257749e-01 | 0.139 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 7.310807e-01 | 0.136 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.336952e-01 | 0.134 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.336952e-01 | 0.134 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 7.363654e-01 | 0.133 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 7.388487e-01 | 0.131 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 7.527780e-01 | 0.123 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 7.584903e-01 | 0.120 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 7.631669e-01 | 0.117 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 7.631669e-01 | 0.117 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 7.699819e-01 | 0.114 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 7.744683e-01 | 0.111 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 7.788374e-01 | 0.109 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 7.809903e-01 | 0.107 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 7.893956e-01 | 0.103 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 7.974803e-01 | 0.098 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 7.994528e-01 | 0.097 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.014062e-01 | 0.096 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 8.014062e-01 | 0.096 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 8.032991e-01 | 0.095 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 8.108934e-01 | 0.091 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 8.108934e-01 | 0.091 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 8.113418e-01 | 0.091 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 8.127361e-01 | 0.090 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.145609e-01 | 0.089 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.145609e-01 | 0.089 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.181577e-01 | 0.087 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.199301e-01 | 0.086 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.216852e-01 | 0.085 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 8.302094e-01 | 0.081 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.302094e-01 | 0.081 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 8.388705e-01 | 0.076 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.414671e-01 | 0.075 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 8.430136e-01 | 0.074 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 8.445451e-01 | 0.073 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 8.471428e-01 | 0.072 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.490511e-01 | 0.071 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 8.548579e-01 | 0.068 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 8.561822e-01 | 0.067 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 8.644907e-01 | 0.063 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.671243e-01 | 0.062 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 8.734880e-01 | 0.059 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 8.737555e-01 | 0.059 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 8.747724e-01 | 0.058 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 8.821352e-01 | 0.054 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 8.841889e-01 | 0.053 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 8.897401e-01 | 0.051 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 8.919102e-01 | 0.050 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 8.989442e-01 | 0.046 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 9.000616e-01 | 0.046 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 9.010394e-01 | 0.045 | 0 | 0 |
| M Phase | R-HSA-68886 | 9.040086e-01 | 0.044 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 9.044357e-01 | 0.044 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.099003e-01 | 0.041 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 9.130918e-01 | 0.039 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.146153e-01 | 0.039 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 9.210816e-01 | 0.036 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.213200e-01 | 0.036 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 9.261924e-01 | 0.033 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.302580e-01 | 0.031 | 0 | 0 |
| Translation | R-HSA-72766 | 9.340945e-01 | 0.030 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 9.567725e-01 | 0.019 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.621149e-01 | 0.017 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.655642e-01 | 0.015 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.829752e-01 | 0.007 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.831237e-01 | 0.007 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.834756e-01 | 0.007 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.975807e-01 | 0.001 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.981939e-01 | 0.001 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999556e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999684e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.110223e-16 | 15.955 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.110223e-16 | 15.955 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.110223e-16 | 15.955 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.110223e-16 | 15.955 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.110223e-16 | 15.955 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.110223e-16 | 15.955 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.110223e-16 | 15.955 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.110223e-16 | 15.955 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.110223e-16 | 15.955 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.110223e-16 | 15.955 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.110223e-16 | 15.955 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.110223e-16 | 15.955 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.220446e-16 | 15.654 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.330669e-16 | 15.477 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 3.330669e-16 | 15.477 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 3.330669e-16 | 15.477 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 4.440892e-16 | 15.353 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 6.661338e-16 | 15.176 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 8.881784e-16 | 15.051 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.332268e-15 | 14.875 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.776357e-15 | 14.750 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 2.664535e-15 | 14.574 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 3.441691e-15 | 14.463 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.087219e-14 | 13.680 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.819966e-14 | 13.550 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.175238e-14 | 13.498 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 3.452794e-14 | 13.462 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 3.930190e-14 | 13.406 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 6.139533e-14 | 13.212 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 8.482104e-14 | 13.071 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.947598e-14 | 13.002 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.306732e-13 | 12.884 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.306732e-13 | 12.884 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.345590e-13 | 12.871 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.671996e-13 | 12.777 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.794120e-13 | 12.746 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.972866e-13 | 12.705 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.996181e-13 | 12.700 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 2.754463e-13 | 12.560 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 2.754463e-13 | 12.560 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 4.548584e-13 | 12.342 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 5.160317e-13 | 12.287 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 7.095435e-13 | 12.149 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 7.076562e-13 | 12.150 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 7.810419e-13 | 12.107 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 8.041345e-13 | 12.095 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.004752e-12 | 11.998 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.238232e-12 | 11.907 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 1.631695e-12 | 11.787 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.867950e-12 | 11.729 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 2.443490e-12 | 11.612 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.426837e-12 | 11.615 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 2.773670e-12 | 11.557 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 2.773670e-12 | 11.557 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.662071e-12 | 11.436 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 4.592993e-12 | 11.338 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 5.856871e-12 | 11.232 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 5.856871e-12 | 11.232 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 6.687317e-12 | 11.175 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 7.876255e-12 | 11.104 | 0 | 0 |
| Depurination | R-HSA-73927 | 7.426393e-12 | 11.129 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 9.782952e-12 | 11.010 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 9.782952e-12 | 11.010 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.174938e-11 | 10.930 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.174938e-11 | 10.930 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.177780e-11 | 10.929 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.466716e-11 | 10.834 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.466716e-11 | 10.834 | 0 | 0 |
| Protein folding | R-HSA-391251 | 2.004241e-11 | 10.698 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 2.253520e-11 | 10.647 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 2.253520e-11 | 10.647 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 2.774692e-11 | 10.557 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.583300e-11 | 10.588 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.363776e-11 | 10.473 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 3.497591e-11 | 10.456 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.729272e-11 | 10.428 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.154121e-11 | 10.382 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.154121e-11 | 10.382 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 4.670730e-11 | 10.331 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.670730e-11 | 10.331 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 5.757239e-11 | 10.240 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 6.942102e-11 | 10.159 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 6.942102e-11 | 10.159 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 7.392065e-11 | 10.131 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 7.895595e-11 | 10.103 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 8.561751e-11 | 10.067 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.256125e-10 | 9.901 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.256125e-10 | 9.901 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.423247e-10 | 9.847 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.350530e-10 | 9.869 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.518331e-10 | 9.819 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.818083e-10 | 9.740 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.818083e-10 | 9.740 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.825705e-10 | 9.739 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.102470e-10 | 9.677 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 2.135573e-10 | 9.670 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.521758e-10 | 9.598 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 2.562925e-10 | 9.591 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 2.928038e-10 | 9.533 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.405539e-10 | 9.468 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.639115e-10 | 9.439 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 4.085037e-10 | 9.389 | 0 | 0 |
| Disease | R-HSA-1643685 | 3.721913e-10 | 9.429 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 4.602367e-10 | 9.337 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 4.620035e-10 | 9.335 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 4.721695e-10 | 9.326 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.772955e-10 | 9.321 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 5.563071e-10 | 9.255 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 5.866873e-10 | 9.232 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 6.918794e-10 | 9.160 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 8.685901e-10 | 9.061 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 8.685901e-10 | 9.061 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 8.841953e-10 | 9.053 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 8.853626e-10 | 9.053 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 9.140015e-10 | 9.039 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.000088e-09 | 9.000 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.329778e-09 | 8.876 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.526359e-09 | 8.816 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.353686e-09 | 8.868 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.329778e-09 | 8.876 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.539571e-09 | 8.813 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.635525e-09 | 8.786 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.690931e-09 | 8.772 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.748578e-09 | 8.757 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.215408e-09 | 8.655 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.251236e-09 | 8.648 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 2.281821e-09 | 8.642 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.281821e-09 | 8.642 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.340246e-09 | 8.631 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.361163e-09 | 8.627 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 2.515033e-09 | 8.599 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.599512e-09 | 8.585 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 3.223868e-09 | 8.492 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 3.223868e-09 | 8.492 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 3.223868e-09 | 8.492 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.356102e-09 | 8.474 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 3.547932e-09 | 8.450 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 3.863176e-09 | 8.413 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 4.303931e-09 | 8.366 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 4.862188e-09 | 8.313 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 6.607286e-09 | 8.180 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 6.186641e-09 | 8.209 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 5.855861e-09 | 8.232 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 7.156634e-09 | 8.145 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 7.799794e-09 | 8.108 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 7.899832e-09 | 8.102 | 0 | 0 |
| Immune System | R-HSA-168256 | 7.982841e-09 | 8.098 | 1 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 8.555614e-09 | 8.068 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 8.746163e-09 | 8.058 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.077016e-09 | 8.042 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.472932e-09 | 8.024 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 9.597865e-09 | 8.018 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 9.597865e-09 | 8.018 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.223082e-08 | 7.913 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.307253e-08 | 7.884 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.791186e-08 | 7.747 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 2.558923e-08 | 7.592 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.660748e-08 | 7.575 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 2.864869e-08 | 7.543 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.121601e-08 | 7.506 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.014607e-08 | 7.396 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.318689e-08 | 7.365 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 5.143950e-08 | 7.289 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 5.455711e-08 | 7.263 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 6.541161e-08 | 7.184 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 7.745692e-08 | 7.111 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 9.561119e-08 | 7.019 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.636530e-08 | 7.016 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.636530e-08 | 7.016 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.636530e-08 | 7.016 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.238661e-07 | 6.907 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.238661e-07 | 6.907 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.432551e-07 | 6.844 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.465986e-07 | 6.834 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.501218e-07 | 6.824 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.403301e-07 | 6.619 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 2.822134e-07 | 6.549 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 3.133585e-07 | 6.504 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 4.014062e-07 | 6.396 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 5.959071e-07 | 6.225 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 5.959071e-07 | 6.225 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 5.969728e-07 | 6.224 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 7.041414e-07 | 6.152 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 7.068506e-07 | 6.151 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 7.585887e-07 | 6.120 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 7.843814e-07 | 6.105 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 8.330373e-07 | 6.079 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 8.974214e-07 | 6.047 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.006208e-06 | 5.997 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.207321e-06 | 5.918 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.820598e-06 | 5.740 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 3.169583e-06 | 5.499 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 3.174909e-06 | 5.498 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 3.458006e-06 | 5.461 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 3.896614e-06 | 5.409 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 4.378604e-06 | 5.359 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 4.991167e-06 | 5.302 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 5.928744e-06 | 5.227 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 8.310039e-06 | 5.080 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.073942e-05 | 4.969 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.512609e-05 | 4.820 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.656130e-05 | 4.781 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.973577e-05 | 4.705 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.999621e-05 | 4.699 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 2.481316e-05 | 4.605 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 3.777548e-05 | 4.423 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.321502e-05 | 4.364 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 4.455748e-05 | 4.351 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 6.253335e-05 | 4.204 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 7.404503e-05 | 4.131 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 7.404503e-05 | 4.131 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 8.824380e-05 | 4.054 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.410252e-04 | 3.851 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.454593e-04 | 3.837 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.534796e-04 | 3.814 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.726568e-04 | 3.763 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.861857e-04 | 3.730 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.478434e-04 | 3.606 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.185379e-04 | 3.660 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.103158e-04 | 3.677 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.125656e-04 | 3.505 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 3.132316e-04 | 3.504 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 4.407180e-04 | 3.356 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.554602e-04 | 3.342 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 4.583657e-04 | 3.339 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 5.218829e-04 | 3.282 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 5.651600e-04 | 3.248 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 5.955683e-04 | 3.225 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 7.404763e-04 | 3.130 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 8.784608e-04 | 3.056 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.856686e-04 | 3.006 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.308709e-03 | 2.883 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.520303e-03 | 2.818 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.709035e-03 | 2.767 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.716175e-03 | 2.765 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.870438e-03 | 2.728 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 2.063079e-03 | 2.685 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.132816e-03 | 2.671 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 2.140933e-03 | 2.669 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.236223e-03 | 2.650 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.377782e-03 | 2.624 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.516039e-03 | 2.599 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.516039e-03 | 2.599 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 3.075495e-03 | 2.512 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 3.552514e-03 | 2.449 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 3.552514e-03 | 2.449 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 3.552514e-03 | 2.449 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 3.552514e-03 | 2.449 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.811780e-03 | 2.419 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 4.610349e-03 | 2.336 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 4.610349e-03 | 2.336 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 4.863990e-03 | 2.313 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 5.628377e-03 | 2.250 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 5.960478e-03 | 2.225 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.960478e-03 | 2.225 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 6.776402e-03 | 2.169 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 6.955032e-03 | 2.158 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 7.158842e-03 | 2.145 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 8.456666e-03 | 2.073 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 8.456666e-03 | 2.073 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 8.727288e-03 | 2.059 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 8.853490e-03 | 2.053 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 9.631704e-03 | 2.016 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 9.851575e-03 | 2.006 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.005729e-02 | 1.998 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.043861e-02 | 1.981 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.130036e-02 | 1.947 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.130036e-02 | 1.947 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.130036e-02 | 1.947 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.130036e-02 | 1.947 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.130036e-02 | 1.947 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.130036e-02 | 1.947 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.134123e-02 | 1.945 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.258482e-02 | 1.900 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.300168e-02 | 1.886 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.309611e-02 | 1.883 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.309611e-02 | 1.883 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.365337e-02 | 1.865 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.365337e-02 | 1.865 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.459565e-02 | 1.836 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.481261e-02 | 1.829 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 1.600118e-02 | 1.796 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 1.757862e-02 | 1.755 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.214308e-02 | 1.655 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.820203e-02 | 1.740 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.229181e-02 | 1.652 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.788562e-02 | 1.747 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.013178e-02 | 1.696 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.214308e-02 | 1.655 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 1.975026e-02 | 1.704 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.820203e-02 | 1.740 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.660940e-02 | 1.575 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 2.423387e-02 | 1.616 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 1.935176e-02 | 1.713 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.200995e-02 | 1.657 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.864581e-02 | 1.543 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.985891e-02 | 1.525 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.993586e-02 | 1.524 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 3.096300e-02 | 1.509 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 3.096300e-02 | 1.509 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.096300e-02 | 1.509 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 3.168255e-02 | 1.499 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 3.168255e-02 | 1.499 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 3.168255e-02 | 1.499 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 3.302441e-02 | 1.481 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.302441e-02 | 1.481 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 3.335176e-02 | 1.477 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 3.352148e-02 | 1.475 | 0 | 0 |
| Defective HK1 causes hexokinase deficiency (HK deficiency) | R-HSA-5619056 | 3.352148e-02 | 1.475 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 3.371876e-02 | 1.472 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 3.439552e-02 | 1.463 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.451739e-02 | 1.462 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 3.579578e-02 | 1.446 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 3.581019e-02 | 1.446 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.581019e-02 | 1.446 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 3.722508e-02 | 1.429 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 3.722508e-02 | 1.429 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.777401e-02 | 1.423 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.833643e-02 | 1.416 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.833643e-02 | 1.416 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 4.092865e-02 | 1.388 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 4.092865e-02 | 1.388 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 4.363194e-02 | 1.360 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 4.431845e-02 | 1.353 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.444506e-02 | 1.352 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.444506e-02 | 1.352 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.444506e-02 | 1.352 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.444506e-02 | 1.352 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.444506e-02 | 1.352 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.444506e-02 | 1.352 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.444506e-02 | 1.352 | 0 | 0 |
| Defective AHCY causes HMAHCHD | R-HSA-5578997 | 4.444506e-02 | 1.352 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.444506e-02 | 1.352 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.444506e-02 | 1.352 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.444506e-02 | 1.352 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.444506e-02 | 1.352 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.444506e-02 | 1.352 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 4.630389e-02 | 1.334 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 4.630389e-02 | 1.334 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 4.768286e-02 | 1.322 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.905698e-02 | 1.309 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 5.152720e-02 | 1.288 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 5.372424e-02 | 1.270 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 5.481773e-02 | 1.261 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.481773e-02 | 1.261 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.524584e-02 | 1.258 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 5.658872e-02 | 1.247 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 5.658872e-02 | 1.247 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 5.976467e-02 | 1.224 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 6.077479e-02 | 1.216 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 6.592520e-02 | 1.181 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 7.648449e-02 | 1.116 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 8.692507e-02 | 1.061 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 8.692507e-02 | 1.061 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 8.692507e-02 | 1.061 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 8.692507e-02 | 1.061 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 9.724824e-02 | 1.012 | 0 | 0 |
| Chylomicron clearance | R-HSA-8964026 | 9.724824e-02 | 1.012 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 9.724824e-02 | 1.012 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 9.724824e-02 | 1.012 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 9.724824e-02 | 1.012 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.074553e-01 | 0.969 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 1.074553e-01 | 0.969 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.074553e-01 | 0.969 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 1.175476e-01 | 0.930 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 1.175476e-01 | 0.930 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 1.175476e-01 | 0.930 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.175476e-01 | 0.930 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.175476e-01 | 0.930 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.275265e-01 | 0.894 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 7.655906e-02 | 1.116 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.262082e-01 | 0.899 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.262082e-01 | 0.899 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 9.712965e-02 | 1.013 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 1.187119e-01 | 0.926 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 7.330638e-02 | 1.135 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 6.694178e-02 | 1.174 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.658131e-02 | 1.063 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.135956e-01 | 0.945 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 7.648449e-02 | 1.116 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 6.383282e-02 | 1.195 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.985671e-02 | 1.098 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.113340e-01 | 0.953 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 8.692507e-02 | 1.061 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 1.052336e-01 | 0.978 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 1.052336e-01 | 0.978 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 1.052336e-01 | 0.978 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.040838e-01 | 0.983 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 8.692507e-02 | 1.061 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 1.074553e-01 | 0.969 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 1.040838e-01 | 0.983 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 6.581634e-02 | 1.182 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.275265e-01 | 0.894 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 7.010013e-02 | 1.154 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.658131e-02 | 1.063 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 7.330638e-02 | 1.135 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.673610e-02 | 1.115 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 6.592520e-02 | 1.181 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 7.648449e-02 | 1.116 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 1.175476e-01 | 0.930 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.275265e-01 | 0.894 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.275265e-01 | 0.894 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 1.005096e-01 | 0.998 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 7.058226e-02 | 1.151 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 1.160402e-01 | 0.935 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.005096e-01 | 0.998 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.181889e-01 | 0.927 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 7.648449e-02 | 1.116 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 7.648449e-02 | 1.116 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 7.648449e-02 | 1.116 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 8.692507e-02 | 1.061 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 9.724824e-02 | 1.012 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.074553e-01 | 0.969 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 1.275265e-01 | 0.894 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.184821e-01 | 0.926 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 8.692507e-02 | 1.061 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 8.692507e-02 | 1.061 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 8.692507e-02 | 1.061 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 9.724824e-02 | 1.012 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 1.275265e-01 | 0.894 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 6.694178e-02 | 1.174 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.346913e-02 | 1.029 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.263601e-01 | 0.898 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.275265e-01 | 0.894 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 7.773501e-02 | 1.109 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 9.497188e-02 | 1.022 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.330638e-02 | 1.135 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 9.000549e-02 | 1.046 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.346913e-02 | 1.029 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.113340e-01 | 0.953 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.494628e-02 | 1.023 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 7.648449e-02 | 1.116 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 1.041278e-01 | 0.982 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 6.581634e-02 | 1.182 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 9.052494e-02 | 1.043 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 6.383282e-02 | 1.195 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 7.985671e-02 | 1.098 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.258895e-01 | 0.900 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.064697e-01 | 0.973 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 6.383282e-02 | 1.195 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 7.655906e-02 | 1.116 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.658131e-02 | 1.063 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 1.150076e-01 | 0.939 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.346913e-02 | 1.029 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.150076e-01 | 0.939 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.150076e-01 | 0.939 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.187119e-01 | 0.926 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 8.658131e-02 | 1.063 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 9.697092e-02 | 1.013 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.299979e-01 | 0.886 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.309723e-01 | 0.883 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.337968e-01 | 0.874 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 1.373930e-01 | 0.862 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.373930e-01 | 0.862 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 1.373930e-01 | 0.862 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.373930e-01 | 0.862 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 1.373930e-01 | 0.862 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.373930e-01 | 0.862 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.373930e-01 | 0.862 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.376550e-01 | 0.861 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.376550e-01 | 0.861 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.376550e-01 | 0.861 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 1.419029e-01 | 0.848 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.419951e-01 | 0.848 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.439028e-01 | 0.842 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 1.471486e-01 | 0.832 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.471486e-01 | 0.832 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 1.471486e-01 | 0.832 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.493192e-01 | 0.826 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 1.493192e-01 | 0.826 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.511792e-01 | 0.821 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.519663e-01 | 0.818 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.532508e-01 | 0.815 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.532508e-01 | 0.815 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.545392e-01 | 0.811 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.545392e-01 | 0.811 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.545392e-01 | 0.811 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 1.567945e-01 | 0.805 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 1.567945e-01 | 0.805 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.567945e-01 | 0.805 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.567945e-01 | 0.805 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.567945e-01 | 0.805 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.567945e-01 | 0.805 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.572025e-01 | 0.804 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.611735e-01 | 0.793 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.651627e-01 | 0.782 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.651627e-01 | 0.782 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.651627e-01 | 0.782 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 1.663319e-01 | 0.779 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 1.663319e-01 | 0.779 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.663319e-01 | 0.779 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.663319e-01 | 0.779 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.663319e-01 | 0.779 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 1.663319e-01 | 0.779 | 0 | 0 |
| Synthesis of GDP-mannose | R-HSA-446205 | 1.663319e-01 | 0.779 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.691693e-01 | 0.772 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 1.701543e-01 | 0.769 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.731923e-01 | 0.761 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.737156e-01 | 0.760 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.757619e-01 | 0.755 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.757619e-01 | 0.755 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.757619e-01 | 0.755 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.757619e-01 | 0.755 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 1.757619e-01 | 0.755 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.757619e-01 | 0.755 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.812843e-01 | 0.742 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 1.850859e-01 | 0.733 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.850859e-01 | 0.733 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.850859e-01 | 0.733 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 1.850859e-01 | 0.733 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.850859e-01 | 0.733 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.890864e-01 | 0.723 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 1.894318e-01 | 0.723 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.935243e-01 | 0.713 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 1.943050e-01 | 0.712 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.943050e-01 | 0.712 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.943050e-01 | 0.712 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.943050e-01 | 0.712 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.943050e-01 | 0.712 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.943050e-01 | 0.712 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 1.943050e-01 | 0.712 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 1.976283e-01 | 0.704 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.992817e-01 | 0.701 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.034203e-01 | 0.692 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.034203e-01 | 0.692 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 2.034203e-01 | 0.692 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.034203e-01 | 0.692 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 2.034203e-01 | 0.692 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.034203e-01 | 0.692 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.079983e-01 | 0.682 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 2.124331e-01 | 0.673 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 2.124331e-01 | 0.673 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 2.124331e-01 | 0.673 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 2.124331e-01 | 0.673 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.124331e-01 | 0.673 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.124331e-01 | 0.673 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 2.124331e-01 | 0.673 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.124331e-01 | 0.673 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 2.210088e-01 | 0.656 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.213444e-01 | 0.655 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.213444e-01 | 0.655 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.213444e-01 | 0.655 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 2.213444e-01 | 0.655 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.213444e-01 | 0.655 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 2.213444e-01 | 0.655 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 2.213444e-01 | 0.655 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 2.213444e-01 | 0.655 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 2.224503e-01 | 0.653 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 2.224503e-01 | 0.653 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 2.266136e-01 | 0.645 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 2.266136e-01 | 0.645 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 2.301555e-01 | 0.638 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.301555e-01 | 0.638 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.301555e-01 | 0.638 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.301555e-01 | 0.638 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.307826e-01 | 0.637 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.312807e-01 | 0.636 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 2.312909e-01 | 0.636 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 2.388674e-01 | 0.622 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.388674e-01 | 0.622 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.388674e-01 | 0.622 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 2.474812e-01 | 0.606 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 2.474812e-01 | 0.606 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.474812e-01 | 0.606 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.474812e-01 | 0.606 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.474812e-01 | 0.606 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.475024e-01 | 0.606 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.543762e-01 | 0.595 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 2.558800e-01 | 0.592 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.558800e-01 | 0.592 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.559981e-01 | 0.592 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.559981e-01 | 0.592 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.559981e-01 | 0.592 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 2.559981e-01 | 0.592 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 2.559981e-01 | 0.592 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 2.559981e-01 | 0.592 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 2.586353e-01 | 0.587 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 2.586353e-01 | 0.587 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.644191e-01 | 0.578 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 2.644191e-01 | 0.578 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.644191e-01 | 0.578 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 2.644191e-01 | 0.578 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 2.684553e-01 | 0.571 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.688258e-01 | 0.571 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.727453e-01 | 0.564 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 2.727453e-01 | 0.564 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.727453e-01 | 0.564 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 2.727453e-01 | 0.564 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.740363e-01 | 0.562 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 2.741422e-01 | 0.562 | 1 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 2.809778e-01 | 0.551 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.809778e-01 | 0.551 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 2.809778e-01 | 0.551 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.809778e-01 | 0.551 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.809778e-01 | 0.551 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 2.891176e-01 | 0.539 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.891176e-01 | 0.539 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 2.891176e-01 | 0.539 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 2.894018e-01 | 0.538 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.924696e-01 | 0.534 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.971657e-01 | 0.527 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 2.971657e-01 | 0.527 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 2.971657e-01 | 0.527 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.971657e-01 | 0.527 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.971657e-01 | 0.527 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.971657e-01 | 0.527 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 2.971657e-01 | 0.527 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 3.017206e-01 | 0.520 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 3.019402e-01 | 0.520 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 3.048079e-01 | 0.516 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.051232e-01 | 0.516 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 3.051232e-01 | 0.516 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 3.051232e-01 | 0.516 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 3.051232e-01 | 0.516 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 3.078967e-01 | 0.512 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.129911e-01 | 0.504 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.129911e-01 | 0.504 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 3.129911e-01 | 0.504 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 3.129911e-01 | 0.504 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 3.129911e-01 | 0.504 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.129911e-01 | 0.504 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 3.129911e-01 | 0.504 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 3.202619e-01 | 0.494 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.207704e-01 | 0.494 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.207704e-01 | 0.494 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 3.207704e-01 | 0.494 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.207704e-01 | 0.494 | 0 | 0 |
| Iron assimilation using enterobactin | R-HSA-9638334 | 3.207704e-01 | 0.494 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 3.207704e-01 | 0.494 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 3.268931e-01 | 0.486 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.284621e-01 | 0.484 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.284621e-01 | 0.484 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.284621e-01 | 0.484 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.295406e-01 | 0.482 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.360672e-01 | 0.474 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.360672e-01 | 0.474 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 3.360672e-01 | 0.474 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 3.360672e-01 | 0.474 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.360672e-01 | 0.474 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 3.360672e-01 | 0.474 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 3.419085e-01 | 0.466 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.435866e-01 | 0.464 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 3.435866e-01 | 0.464 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 3.435866e-01 | 0.464 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.435866e-01 | 0.464 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 3.435866e-01 | 0.464 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.475087e-01 | 0.459 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 3.510213e-01 | 0.455 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 3.510213e-01 | 0.455 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.583722e-01 | 0.446 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.583722e-01 | 0.446 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.583722e-01 | 0.446 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.583722e-01 | 0.446 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.583722e-01 | 0.446 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.597796e-01 | 0.444 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 3.597796e-01 | 0.444 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 3.656403e-01 | 0.437 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.656403e-01 | 0.437 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.679137e-01 | 0.434 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.728266e-01 | 0.428 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 3.728266e-01 | 0.428 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 3.728266e-01 | 0.428 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 3.728266e-01 | 0.428 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 3.728266e-01 | 0.428 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 3.760078e-01 | 0.425 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.799319e-01 | 0.420 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 3.799319e-01 | 0.420 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 3.799319e-01 | 0.420 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.799319e-01 | 0.420 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 3.799319e-01 | 0.420 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 3.799319e-01 | 0.420 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 3.799319e-01 | 0.420 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 3.869571e-01 | 0.412 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 3.869571e-01 | 0.412 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 3.869571e-01 | 0.412 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 3.939031e-01 | 0.405 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 3.939031e-01 | 0.405 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 3.939031e-01 | 0.405 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 3.939031e-01 | 0.405 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.939031e-01 | 0.405 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 3.960527e-01 | 0.402 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.960527e-01 | 0.402 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 4.007709e-01 | 0.397 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.007709e-01 | 0.397 | 0 | 0 |
| Translation | R-HSA-72766 | 4.042995e-01 | 0.393 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 4.075613e-01 | 0.390 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.075613e-01 | 0.390 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 4.075613e-01 | 0.390 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 4.075613e-01 | 0.390 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 4.075613e-01 | 0.390 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 4.075613e-01 | 0.390 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 4.075613e-01 | 0.390 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.142751e-01 | 0.383 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.142751e-01 | 0.383 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.142751e-01 | 0.383 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 4.142751e-01 | 0.383 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 4.142751e-01 | 0.383 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 4.209133e-01 | 0.376 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 4.209133e-01 | 0.376 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 4.209133e-01 | 0.376 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 4.209133e-01 | 0.376 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 4.274766e-01 | 0.369 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 4.274766e-01 | 0.369 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 4.274766e-01 | 0.369 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 4.274766e-01 | 0.369 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 4.274766e-01 | 0.369 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 4.274766e-01 | 0.369 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 4.313652e-01 | 0.365 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.339660e-01 | 0.363 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 4.352223e-01 | 0.361 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 4.352223e-01 | 0.361 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 4.403822e-01 | 0.356 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 4.428944e-01 | 0.354 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.467089e-01 | 0.350 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.467260e-01 | 0.350 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 4.467260e-01 | 0.350 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 4.467260e-01 | 0.350 | 0 | 0 |
| Methylation | R-HSA-156581 | 4.467260e-01 | 0.350 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.467260e-01 | 0.350 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.467260e-01 | 0.350 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.529984e-01 | 0.344 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 4.529984e-01 | 0.344 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.529984e-01 | 0.344 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 4.529984e-01 | 0.344 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 4.529984e-01 | 0.344 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 4.529984e-01 | 0.344 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 4.529984e-01 | 0.344 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 4.529984e-01 | 0.344 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 4.529984e-01 | 0.344 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 4.542943e-01 | 0.343 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.592000e-01 | 0.338 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 4.592000e-01 | 0.338 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 4.592000e-01 | 0.338 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.592000e-01 | 0.338 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 4.629695e-01 | 0.334 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 4.713942e-01 | 0.327 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 4.713942e-01 | 0.327 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.833149e-01 | 0.316 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 4.833149e-01 | 0.316 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.840312e-01 | 0.315 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 4.891746e-01 | 0.311 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 4.891746e-01 | 0.311 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 4.891746e-01 | 0.311 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 4.913089e-01 | 0.309 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.949683e-01 | 0.305 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.949683e-01 | 0.305 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 4.949683e-01 | 0.305 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.949683e-01 | 0.305 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 5.006965e-01 | 0.300 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 5.006965e-01 | 0.300 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 5.006965e-01 | 0.300 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 5.021045e-01 | 0.299 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 5.063602e-01 | 0.296 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.174965e-01 | 0.286 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 5.197681e-01 | 0.284 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 5.267165e-01 | 0.278 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.283829e-01 | 0.277 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 5.283829e-01 | 0.277 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 5.337342e-01 | 0.273 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 5.337342e-01 | 0.273 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 5.337342e-01 | 0.273 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.337342e-01 | 0.273 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 5.390250e-01 | 0.268 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 5.390250e-01 | 0.268 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 5.391293e-01 | 0.268 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 5.442562e-01 | 0.264 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 5.442562e-01 | 0.264 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 5.442562e-01 | 0.264 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.494283e-01 | 0.260 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.494283e-01 | 0.260 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.545420e-01 | 0.256 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.545420e-01 | 0.256 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.595980e-01 | 0.252 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 5.604338e-01 | 0.251 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.637105e-01 | 0.249 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 5.645969e-01 | 0.248 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 5.702115e-01 | 0.244 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 5.744261e-01 | 0.241 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 5.766426e-01 | 0.239 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.792576e-01 | 0.237 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.861579e-01 | 0.232 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.887576e-01 | 0.230 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 5.934273e-01 | 0.227 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 5.934273e-01 | 0.227 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 5.934273e-01 | 0.227 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 5.955152e-01 | 0.225 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 5.980442e-01 | 0.223 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 5.980442e-01 | 0.223 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 5.980442e-01 | 0.223 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 6.026090e-01 | 0.220 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 6.026090e-01 | 0.220 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 6.071223e-01 | 0.217 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 6.115845e-01 | 0.214 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 6.203584e-01 | 0.207 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 6.246711e-01 | 0.204 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 6.246711e-01 | 0.204 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 6.246711e-01 | 0.204 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 6.289351e-01 | 0.201 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 6.289351e-01 | 0.201 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.331509e-01 | 0.198 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.331509e-01 | 0.198 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 6.414401e-01 | 0.193 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 6.455146e-01 | 0.190 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 6.455146e-01 | 0.190 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.495431e-01 | 0.187 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 6.535260e-01 | 0.185 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 6.574639e-01 | 0.182 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 6.574639e-01 | 0.182 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.574639e-01 | 0.182 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.593188e-01 | 0.181 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 6.613573e-01 | 0.180 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 6.727753e-01 | 0.172 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 6.764956e-01 | 0.170 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.801738e-01 | 0.167 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 6.838104e-01 | 0.165 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 6.874059e-01 | 0.163 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 6.909607e-01 | 0.161 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 6.944753e-01 | 0.158 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.979502e-01 | 0.156 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 7.013857e-01 | 0.154 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 7.013857e-01 | 0.154 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 7.013857e-01 | 0.154 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 7.047824e-01 | 0.152 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 7.081406e-01 | 0.150 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 7.114609e-01 | 0.148 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.114609e-01 | 0.148 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 7.195037e-01 | 0.143 | 1 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 7.211980e-01 | 0.142 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 7.211980e-01 | 0.142 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.211980e-01 | 0.142 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 7.275071e-01 | 0.138 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 7.306082e-01 | 0.136 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 7.306082e-01 | 0.136 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.367054e-01 | 0.133 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.367054e-01 | 0.133 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.397024e-01 | 0.131 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.426655e-01 | 0.129 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 7.455950e-01 | 0.127 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.513548e-01 | 0.124 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.513548e-01 | 0.124 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.569850e-01 | 0.121 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.569850e-01 | 0.121 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 7.569850e-01 | 0.121 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.569850e-01 | 0.121 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 7.651934e-01 | 0.116 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 7.705118e-01 | 0.113 | 1 | 1 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 7.705118e-01 | 0.113 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.757104e-01 | 0.110 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 7.893049e-01 | 0.103 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 7.906139e-01 | 0.102 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 7.930003e-01 | 0.101 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 7.999982e-01 | 0.097 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 8.083889e-01 | 0.092 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 8.132959e-01 | 0.090 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 8.139709e-01 | 0.089 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 8.316113e-01 | 0.080 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 8.428173e-01 | 0.074 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.498727e-01 | 0.071 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.515868e-01 | 0.070 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.566130e-01 | 0.067 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.592925e-01 | 0.066 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 8.646167e-01 | 0.063 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.676923e-01 | 0.062 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 8.748348e-01 | 0.058 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.793152e-01 | 0.056 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.847400e-01 | 0.053 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 8.860579e-01 | 0.053 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.860579e-01 | 0.053 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 8.886488e-01 | 0.051 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 8.886488e-01 | 0.051 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 8.948726e-01 | 0.048 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.018861e-01 | 0.045 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.063012e-01 | 0.043 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.094823e-01 | 0.041 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.115431e-01 | 0.040 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.180139e-01 | 0.037 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 9.211680e-01 | 0.036 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.247195e-01 | 0.034 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.344473e-01 | 0.029 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.346985e-01 | 0.029 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.366771e-01 | 0.028 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.442266e-01 | 0.025 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.453969e-01 | 0.024 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.485576e-01 | 0.023 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.643106e-01 | 0.016 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.672320e-01 | 0.014 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.814337e-01 | 0.008 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.862647e-01 | 0.006 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.909136e-01 | 0.004 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.927717e-01 | 0.003 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.989440e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.993225e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 9.999864e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999997e-01 | 0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
